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Abstract
Proton therapy is a method of radiotherapy utilising protons to deliver a
therapeutic dose of radiation to target cancer. Unlike x-rays, protons in the thera-
peutic energy range (< 250 MeV) have a finite range in the body. The physics of
proton interactions mean that protons deposit most of their radiation dose at the
end of their range. Hence, through careful selection of proton energy, protons have
the potential to deliver dose to the target whilst sparing healthy surrounding tissue,
as well as reducing the total dose given to the patient. This is particularly favourable
for paediatric patients. However, the accuracy of proton therapy is currently limited
by uncertainty in the delivered proton range. Because of this range uncertainty, a
margin of typically 3.5 mm + 3% is added to the proton range. A major source of
range uncertainty in proton therapy arises from the use of x-ray CT when imaging
the patient for treatment planning. Here, an alternative imaging modality is tested
in an effort to reduce range uncertainty.
A proposed solution to remove this source of uncertainty is the use of pro-
ton CT. In proton CT, the stopping power relative to water (RSP) of the patient is
measured directly, potentially increasing the accuracy of imaging for proton therapy
treatment planning. The PRaVDA prototype proton CT system is a proton-tracking
CT system designed using fully solid-state technology to resolve the paths of indi-
vidual protons entering and exiting a phantom, and then measure the residual range
of the phantom. With this information, an image is constructed of proton stopping
power.
In this thesis, the first results from the PRaVDA proton CT system are
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shown. An image of a test phantom was acquired and the RSP accuracy of the
image was shown to be better than 1.3% in materials replicating soft tissue and
bone. The image contained artefacts arising from the raw data acquired and the
source of these artefacts is investigated. Further study into the use of proton CT for
proton range calculation was performed using a dosimetric phantom. The dosimetric
phantom contains a section of EBT-3 radiochromic film capable of measuring a 2D
dose distribution. The phantom was exposed to proton beams at two different
energies, and images of the phantom were acquired using proton CT and x-ray CT.
The proton CT and x-ray CT images were used to calculate the expected proton
range using a validated Monte Carlo simulation, and the simulated results were
compared against the experimental measurement.
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Chapter 1
Introduction
Proton therapy uses protons to deliver a therapeutic dose of ionising radiation to
damage cancer cells. First proposed by Robert Wilson in 1946 [1], protons in the
therapeutic energy range (50-250 MeV) have a finite range in tissue and deposit
dose as they lose energy. Protons, amongst other heavy ions, may be considered
advantageous to x-rays in radiation therapy due to their highly selective dose de-
position, as they deliver most of their radiation dose at the end of their range.
Through careful selection and modulation of the beam energy, the proton range can
be adjusted to target the cancer with a radiation dose whilst sparing surrounding
healthy tissue and anything beyond the range of the beam. However, uncertainty
in the range of the delivered proton beam leads to an uncertainty in the position of
the delivered dose. Consequently, proton treatment plans are designed with large
margins reducing the ability to use proton therapy to its full potential.
A major contributor to the proton range uncertainty arises from the use of
x-ray CT imaging, used to plan proton therapy treatments. A 3D image of the
subject is produced based on x-ray attenuation and is used to inform, amongst
other things, the required range and therefore the energy of the therapeutic proton
beam. To use the data for treatment planning, the images must be converted from
x-ray attenuation to proton stopping powers. Whilst x-ray attenuation is mostly
dependent on electron density, proton stopping powers are also dependent on the
mean excitation energy, or I-value, which roughly scales with the atomic number,
or Z-number, of the material. This causes a degeneracy in the conversion of x-
ray attenuation to proton stopping powers. The degeneracy is accounted for by
adding uncertainty to the converted stopping power values which in turn results in
an uncertainty in the delivered proton range [2]. A proposed solution is to image the
patient using protons, directly measuring the proton stopping power of the patient.
1
This is known as proton computed tomography (proton CT).
This thesis will cover work done to aid the calibration and evaluation of a
novel prototype proton CT system constructed by the PRaVDA Collaboration.
1.1 Radiation Therapy
Radiation therapy, or radiotherapy, is a method of cancer treatment that uses ion-
ising radiation to damage or kill tumour cells. Around 40% of patients with cancer
receive radiotherapy as part of their treatment [3].
The most common method of radiotherapy uses x-rays typically with energies
between 1-20 MeV, generated by accelerating electrons in a linear accelerator on a
gantry and colliding them with a target. The treatment is prescribed in terms of a
radiation dose to the target volume, measured in units of Gray (Gy), where 1 Gy is
1 Joule of energy absorbed by 1 kilogram of mass.
1 Gy =
1 J
1 kg
(1.1)
Typical radiotherapy treatments aim to deliver a dose of around 50 - 70 Gy
to the target volume, fractionated such that the total dose is delivered daily over
a period of several weeks [4]. Therefore, it is important to ensure that the dose
delivery is both highly localised and adaptable to daily change, as well as ensuring
that dose to critical organs in the body, that may result in significant impairment
or even death, is kept to a minimum. In order to achieve this in x-ray radiotherapy,
multiple x-ray fields are delivered to the patient using a gantry to deliver dose from
different angles, such that the radiation dose superposes at the target site and the
necessary entry and exit dose is spread around the body, minimising its effect.
An alternative method of radiotherapy is ion therapy. In ion therapy, charged
particles such as protons, helium ions and carbon ions are accelerated to energies of
up to 300 MeV/u in order to deliver a localised dose [5]. Unlike highly penetrating
x-ray beams, these ions lose all of their energy in the patient and come to a stop
meaning that there is no exit dose. Even more critically, the energy loss mechanisms
of these ions mean that they lose the majority of their energy at the point at which
they stop. Therefore, with careful energy selection, it would seem that ion therapy
could be favourable for radiotherapy in terms of minimising the dose delivered to
healthy tissue. For this reason, the NHS has recently invested in two high-energy
proton therapy centres at The Christie Hospital in Manchester and University Col-
lege London Hospital in order to provide a specialist service to treat patients who
would see the most benefit from proton therapy. The first patient is expected to be
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Figure 1.1: Depth-Dose curves for x-rays and protons
treated in 2018.
1.2 Depth-Dose curves
Depth-dose curves show how the radiation dose delivered by radiotherapy varies
over the depth of the patient. Typically, depth-dose curves are shown in water as
water is a useful proxy for tissue. Figure 1.1 compares depth-dose curves for x-rays
and protons.
X-ray radiation absorption is described by linear attenuation meaning there
is a high radiation dose at low depth that reduces exponentially. Therefore, a lot
of healthy tissue may receive a radiation dose. The initial rise in dose over the first
cm of the depth-dose curve is due to Compton scattering, where excited electrons
are forward scattered in the direction of the beam and therefore deposit their dose
further ahead.
For protons, the depth-dose curve is significantly different. A low entrance
dose can be seen, with a sharp rise to a peak and a fall off to zero. This peak is
the Bragg peak, and the aim of ion therapy is to use this peak to treat the tumour.
Other ions (helium, carbon) have very similar depth-dose curves to protons and
generally have narrower Bragg peaks, however due to their lower mass, protons are
easier to accelerate and there is significantly more clinical use of proton therapy
worldwide [6]. This thesis will focus on proton therapy and specifically proton CT
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from this point forward. The dose absorbed in proton therapy is a function of the
fluence of the beam, the stopping power of the absorbing material and the mass
density of the material:
D = Φ
S
ρ
= Φ
1
ρ
dE
dx
(1.2)
where Φ is the fluence of the beam in terms of the number of protons, ρ is the
mass density of the absorber and S is the stopping power of the material; a measure
of the energy absorbed over a unit length [7].
1.3 Bragg Peak
As shown in the depth-dose curves, the Bragg peak is the main advantage in proton
therapy. The Bragg peak arises due to the nature of proton interactions with matter.
The position of the Bragg peak is dependent on the energy of the primary proton
beam and the stopping power of the medium. The initial energy of the proton beam
used in the clinic is often defined by the beam’s range in water. The range of the
beam is defined as the point at which the Bragg peak falls to 80% of its maximum
dose on its distal edge, which can be referred to as R80. This is chosen as it is
approximately the point at which 50% of the protons in the primary beam will have
stopped [7]. The range-energy relationship can then be defined by a power law
R80[cm] = aE
b (1.3)
where a is a material-dependent constant and b is a fitting parameter. A
fit of the proton range in water for energies between 100 MeV and 200 MeV yields
values of 0.00244 and 1.75 for a and b respectively [7], where the proton range in
water was determined from a look-up table published in ICRU report 49 [8].
To demonstrate this, Bragg peaks from proton beams are shown in figure 1.2.
The proton beam with the shortest range is a Monte Carlo simulation of the MC40
cyclotron at the University of Birmingham that provides a 31 MeV beam with an
11 mm range in water. This proton beam was used during the commissioning and
testing of the proton CT system described in this thesis, however the range of the
proton beam is insufficient for proton therapy treatments. The second beam shown
is a 60 MeV proton beam corresponding to the maximum energy output of the
Douglas cyclotron at the Clatterbridge Cancer Centre, Wirral, UK. Clatterbridge
became the world’s first hospital-based proton therapy centre in 1989. This proton
beam has a 31 mm range in water and is used to treat ocular tumours. The final
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Figure 1.2: Depth-Dose curves of proton beams with different initial energies. The
36 MeV is representative of the range of the proton beam from the MC40 cyclotron
at the University of Birmingham. The 60 MeV beam is representative of the beam
from the Douglas Cyclotron at Clatterbridge Cancer Centre, Wirral, used to treat
ocular tumours. The 125 MeV and 200 MeV proton beams are representative of a
clinical proton beam with enough range to deliver a proton therapy treatment.
two Bragg peaks are simulations of a high energy beam suitable for proton therapy.
The 125 MeV beam has a range of approximately 118 mm range in water, and
the 200 MeV beam a range of approximately 26 cm range in water. The maximum
energy output of proton accelerators designed for proton therapy is typically between
200 - 250 MeV, more than sufficient to provide adequate range for proton therapy
treatments [9].
Using the Bragg peak in radiotherapy has a distinct advantage over x-ray
radiotherapy in cases where the tumour is close to critical structures, or in young
patients where the accumulation of dose to healthy tissue may cause growth defects,
affect cognitive development or lead to secondary cancers later in life [10]. An
example of how proton therapy may be advantageous to x-ray radiotherapy is shown
in figure 1.3. The figure shows the dose distribution from two radiotherapy treatment
plans, one using x-rays and one using protons. The proton therapy treatment plan
spares the gastrointestinal system, chest and the heart from radiation dose. The
figure highlights the potential of proton therapy.
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Figure 1.3: Treatment plans showing craniospinal irradiation of a paediatric patient
to treat medulloblastoma. Image a) shows the distribution of dose from a non-
optimized x-ray radiotherapy treatment. Image b) shows the dose distribution from
a proton therapy treatment. Image reproduced with permission from [10].
1.4 Stopping Power
The stopping power S of a material describes the rate of energy loss by the incident
particle over a unit length:
S(E) = −dE
dx
. (1.4)
The stopping power at any given point is dependent on the instantaneous
energy of the incident particle as well as the atomic number and mean excitation
energy, or I-value, of the material. The Bethe-Bloch equation [7, 8] defines the
stopping power of a material for ions in the therapeutic energy range and is given
as:
S
ρ
= −1
ρ
dE
dx
=
4pir2emec
2
β2
1
u
Z
A
z2
[
ln
(
2mec
2β2
1− β2
)
− ln Im − β2
]
(1.5)
where r2e is the classical electron radius, me is the electron mass, u is the
atomic mass unit, β is the velocity of the proton divided by the c, Z and A are the
atomic number and relative atomic mass of the absorber material, z is the charge of
the projectile and Im is the mean excitation energy, or I-value, of the material, given
in eV. The constants 4pir2emc
2/u have an approximate value of 0.307MeV cm2g−2.
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Some publications include a more thorough version of the Bethe-Bloch equation in-
cluding the shell correction and density corrections however these are not relevant
for therapeutic proton therapy [8, 11]. The Bethe-Bloch formula aids in understand-
ing the shape of the Bragg peak. As the proton loses velocity, the rate of energy
loss increases, giving rise to the peak until the proton comes to a stop. Integrating
the Bethe-Bloch formula provides the proton range.
In proton therapy, the Bethe-Bloch formula is used to calculate stopping
powers for human tissues in order to define a conversion curve or look-up table to
estimate stopping powers based on x-ray attenuation. For this purpose it is much
simpler to consider the stopping power of the material relative to water, called
the relative stopping power (RSP). The advantage of using the RSP term is that
provided that the material has a Z-number close to water, the relative stopping
power remains relatively constant with proton energy. Many of the constants in
equation 1.5 also drop out of the equation and we are left with
RSPm = ρe,rel
(
ln 2mec
2β2
(1−β2)Im − β2
)(
ln 2mec
2β2
(1−β2)Iw − β2
) , (1.6)
where ρe,rel is the electron density of the material relative to water, Iw is the
I-value of water and all other terms are previously defined. This formula was first
defined by Schneider et al [12]. With this formula, the RSP of a material can be
calculated from the electron density and the mean ionisation potential.
The I-value of the medium is an average of the excitation energies of a
medium, weighted by their respective dipole oscillator strengths [13]. A first or-
der approximation is that I ≈ Z × 10 eV [8, 14] however the exact I-value of a
material is difficult to calculate accurately from first principles. For this reason,
experimental measurements of I-values for elemental media and a selection of com-
pounds are compiled and published in ICRU Report 49. The I-value for material m
from elemental values can be calculated using the Bragg additivity rule:
ln Im =
(∑
i
ωiZi
Ai
ln Ii
)(∑
i
ωiZi
Ai
)−1
(1.7)
However, the complex nature of bonding in mixtures and compounds means
that Bragg additivity is inexact and leads to uncertainties when calculating the
I-value of materials, typically leading to an uncertainty of 1.5% when calculating
proton ranges [15]. Therefore, a common method for obtaining I-values is to fit the
Bethe-Bloch formula to measured stopping powers, usually through measurements
of proton range. In this way, the I-value is treated as a free parameter that can be
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adjusted to fit a model [11]. Recent work has sought to reduce the uncertainty in
I-values by recalculating all of the elemental I-values such that they are optimised
for use with the Bragg additivity rule [16].
1.5 Multiple Coulomb Scattering
Protons undergo many small deviations from their straight line path due to elec-
tromagnetic reactions with atomic nuclei. These small deviations are known as
multiple Coulomb scattering (MCS). Individual scattering events are almost always
negligible however the sum of many of the scatters in the beam leads to an almost-
Gaussian distribution of proton trajectories. The non-Gaussian elements are due to
large single scatters however these are considered negligible in proton radiotherapy,
and only count for around 2% of the primary proton beam [7].
Whilst a full description of scattering is covered by Molie`re theory, a Gaussian
approximation of the scattering angle given particle energy and material thickness is
much simpler to compute. This approximation is described by Highland’s formula:
θ0 =
(
1 +
1
9
log10
x
X0
)(∫ x
0
(
14.1MeV
pv(x′)
)2 1
X0
dx′
)1/2
rad (1.8)
where X0 is the radiation length of the absorber material and pv is the
particle momentum multiplied by velocity [17]. θ0 is the projected angle of scatter.
The Gaussian approximation can be used to aid the design of scattering filters for
proton therapy [18].
Scatter is a particularly important consideration in proton CT as the image
reconstruction must take into consideration energy losses along non-linear paths. A
number of approaches have been devised to account for scatter by considering the
most-likely path that a proton will take through an object. This can be achieved
provided that accurate positional information is known about each proton used
for imaging [19, 20, 21]. The presence of multiple Coulomb scattering places a
fundamental limit on the spatial resolution achievable by proton CT [22]. We obtain
from equation 1.8 that the scattering angle is dependent on the kinetic energy of
the proton, therefore we can expect less scatter with a higher energy proton beam.
With this knowledge, it is possible to define the scattering power of a material:
T (x) =
d〈θ2y〉
dx
. (1.9)
Provided solely with positional information of each individual proton, it is
therefore possible to perform tomographic reconstructions of scattering power [23],
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as demonstrated by the PRaVDA Collaboration [24]. Whilst there is currently
limited use for this information, it is feasible that scattering power data may be
incorporated into Monte Carlo dose calculation for treatment planning, as knowl-
edge of scattering power reduces uncertainties in the lateral spread of a proton
beam. However, in this thesis we only are concerned with relative stopping power
reconstructions.
1.6 Nuclear Reactions
In addition to the inelastic reactions with atomic electrons and the nucleus, there is
a non-negligible chance of the incident proton undergoing a nonelastic nuclear reac-
tion with the atomic nucleus of the absorber material. In a 160 MeV beam, typically
around 20% of the primary protons will undergo a nuclear reaction with the medium.
In order to undergo a nuclear reaction, the incident proton must have enough energy
to overcome the Coulomb barrier of the nucleus which is around 8 MeV for materials
relevant to proton therapy [25]. Nuclear reactions in proton therapy produce en-
ergetic secondary protons, deuterons, neutrons, gammas, alpha particles and other
ions [7]. For proton CT, the detector systems must be constructed to be robust from
radiation damage from nuclear reactions, known as non-ionising energy loss, that
can cause displacement damage to the crystal lattice in semiconductor detectors.
Some products of nuclear reactions may be used during proton therapy treatment
to monitor the proton range in real-time [26]. For example, prompt-gamma imaging
and positron emission tomography can be employed during treatment to resolve the
source of the emission of secondaries and thus determine the position of the Bragg
peak.
1.7 Summary
Proton therapy provides potential advantages in clinical use compared to conven-
tional x-ray radiotherapy. Not only can critical organs be shielded from dose, but the
patient will receive a lower integral dose to the body. This is particularly important
for young people, where the risks of developing secondary cancers or experiencing
growth defects or cognitive impairment due to the stray radiation dose are much
higher. However, the full benefit of proton therapy may not be realised until the
margins used for treatment planning can be reduced. A major contributor to proton
range uncertainty, used to define the margins, arises from the conversion of x-ray
CT Hounsfield Units (HU) to proton stopping powers. A proposed solution to re-
9
duce this uncertainty is the use of proton tomographic imaging. This thesis will
discuss a method of performing proton CT and demonstrate its use, culminating in
a comparison of Monte Carlo dose calculations performed on x-ray CT and proton
CT data against a measurement taken in a dosimetric phantom.
10
Chapter 2
Proton Computed Tomography
Proton computed tomography (proton CT) is a method of tomographic imaging
using protons. The motivation behind using protons for imaging arises from the
desire to improve the accuracy of imaging for proton therapy in terms of accurate
stopping power data. By using the proton treatment beam to image the patient,
the contrast mechanism is proton stopping power, removing the need for an indirect
conversion from x-ray attenuation currently used when planning proton therapy
treatments [27].
Although the concept of proton CT has been around for as long as x-ray
CT [28], there are no proton CT system in use clinically despite a number of re-
search proton CT systems having been developed [29, 22]. The first experimental
demonstrations of proton CT began in the 1970s. However, the spatial resolution
of these systems suffered as multiple Coulomb scattering (MCS) was not accounted
for [30]. There was an early acceptance that whilst there were benefits to proton
CT, the technology and computing resources to perform a proton CT scan with
sufficient spatial resolution in a clinical time frame were not yet available [31]. In
recent years the growth in proton therapy has renewed interest in proton CT and a
number of research groups are actively developing proton CT systems. Whilst the
choice of specific instrumentation may vary between these systems, they all aim to
reconstruct proton CT images by tracking individual protons and measuring their
residual energy. Two recent reviews of the state of proton CT are [22] and [29].
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2.1 Review
2.1.1 Motivation
The modern motivation for proton computed tomography is to reduce range uncer-
tainty in proton therapy. Range uncertainty refers to the uncertainty in the range
of the delivered beam used in proton therapy. Due to the steep dose gradient at the
Bragg peak, proton therapy is highly sensitive to range uncertainties. Typically, a
margin of the order of 3 - 3.5% is added to the expected proton range to account for
this uncertainty. Because of this margin, the effectiveness of proton therapy is then
reduced and the potential for more advanced treatments, where the distal edge of
the Bragg peak may be used to spare a critical structure, is hindered [26].
Sources of range uncertainty include range straggling, where due to MCS
each individual proton takes a different path thus ‘smearing’ the end of the proton
beam range, patient set-up uncertainty, allowing for a tolerance in the position of the
patient, and variation in the beam energy. Range straggling typically contributes an
uncertainty of 1-2% of the beam range [26, 15] however this is likely to be reduced
with the introduction of Monte Carlo treatment planning. Range uncertainty due
to variation of the beam energy and patient set-up is much more random in nature
and not necessarily dependent on the initial range of the beam. To account for
these random uncertainties, an additional margin of the order of 1.2 mm is added to
the beam range. Nevertheless, the use of proton CT equipment prior to treatment
may have advantages in verifying the energy/range of the beam and also the patient
position.
A major contributor to range uncertainty arises from the imaging modality
currently used for treatment planning: x-ray CT [15, 2]. The significance of x-ray
CT is an uncertainty of up to 3% [32]. Yang et al [2]provided a comprehensive
study of range uncertainty associated with the use of x-ray CT for proton therapy
treatment planning, and the stoichiometric conversion method used to convert x-ray
absorption to proton stopping powers. The method entails a number of steps each
with their own uncertainties. For soft tissue, where the sum of the uncertainties in
quadrature is 1.6%, the individual sources are
• Uncertainties in parameterized stoichiometric formula to calculate CT num-
bers - 0.8%
• Uncertainties due to deviation of human tissue from ICRU standard tissue -
1.2%
• Uncertainties in mean excitation energies - 0.2 %
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• Other sources - 0.6 %
The use of proton CT imaging would remove the first three steps of this
process [22], and while there may be additional uncertainties associated with proton
CT is should be feasible to reduce the total uncertainty - in bone, soft tissue and in
lungs - to 1% or better [33, 29]. For a beam with nominally 10 cm range in water,
this represents reducing the margins from ±3mm to ±1mm.
2.1.2 History
The first proton radiograph was performed in 1968 by Koehler, using a 137 MeV
proton beam at the Harvard cyclotron [34]. A lead scatterer was placed in the beam
to produce a beam with a radius of 10 cm, and a number of aluminium absorber
sheets were placed in the beam path. A piece of photographic film was placed
behind the absorber sheets with the resulting image demonstrating potential for
protons to be used for imaging objects with high contrast, despite the poor spatial
resolution. Koehler published further work in 1976 with Cormack performing the
first quantitative proton CT experiments [30]. Two scintillating counters were used,
one recording signal behind a known thickness of lucite and another recording the
signal behind a phantom that was scanned across the counter. By comparing the
relative counts, the density of the phantom could be reconstructed.
Whilst Koehler continued further work into proton radiography, other groups
began to realise the potential of proton CT to offer better contrast in soft tissue than
x-ray CT imaging, as well as the opportunity to significantly reduce the radiation
dose to a patient given during imaging. Hanson proposed that proton CT may
reduce the necessary imaging dose by up to 90% when compared to x-ray CT, and
also that recording individual proton histories may improve the spatial resolution
of the system. An event rate of 108 protons per second was deemed necessary to
achieve the required timescales for clinical imaging [35]. Around the same time,
Kramer et al demonstrated a system at a synchrotron facility in Argonne with a 205
MeV proton beam [36]. Using scintillator counters upstream and downstream of
the image object, a density phantom and a number of human samples were imaged.
The authors also noted that blurring due to MCS could be reduced if the positional
information could be used in reconstruction.
Hanson et al demonstrated experimental proton CT images taken at the Los
Alamos Meson Physics Facility (LAMPF) in 1982 showing images of test phantoms
and human specimens produced by measuring the exit positions of individual pro-
tons with a multiwire proportional chamber and a range telescope comprising 32
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scintillator plates [37]. The experimental setup devised by Hanson et al with sep-
arate tracking and range detectors is relevant today as many modern systems are
based on this concept [22]. The beam was magnetically scanned with energies of the
order of around 230 MeV, however the scan time was still around 10 hours. Despite
the additional positional information, the reconstruction assumed that straight line
paths were taken by the protons.
A small number of further proton CT systems were developed in the inter-
mediate time however not until the 1990s was a system developed solely focused on
the aim of reducing uncertainty in proton stopping power, fueled by the growth in
interest in proton therapy. Publications from the Paul Scherrer Institute (PSI) are
therefore considered to be the starting point of modern proton imaging [22].
2.1.3 Methodology
The general method of modern day proton CT is to track the position of individual
protons entering and exiting the patient and then measure their residual proton
energy after exiting the patient. Provided with knowledge of the initial beam energy,
the energy loss through the patient can be determined. Non-linear reconstructions
accounting for the most-likely-path that the proton took through the patient allow
for backprojection accounting for MCS [19, 38]. Each proton can then be considered
as a ray projection analogous to x-ray CT and a tomographic reconstruction is
performed.
A schematic of an ideal proton CT system is shown in figure 2.1. In order
to track each proton and determine its path through the patient, position sensitive
detectors (PSDs) are located before and after the patient. Using a pair of PSDs
allows the trajectory of the proton to be determined rather than just the position.
The residual energy of the proton upon exiting the final tracker is determined by a
residual energy-range detector (RERD). This may take the form of a calorimeter,
used to determine proton energy or a range telescope that directly measures the
proton range.
2.1.4 Design Constraints
In order to improve on x-ray CT for proton therapy, a specific aim for proton
CT development is to develop a device capable of reconstructing RSPs with an
accuracy of 1%, yielding a proton range error of less than 1 mm for a beam with
a nominal range of 100 mm [29]. The RSP is reconstructed from measurements of
the water-equivalent path length (WEPL) of protons that have propagated through
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the imaging subject. In research proton CT systems, in the absence of a patient,
phantoms are used as imaging subjects. The WEPL is a line integral of RSP of the
phantom that the proton has propagated. Measurements of the WEPL that protons
have taken are backprojected to obtain RSPs. The WEPL is closely related to the
water equivalent thickness (WET) of a material, however the WET is a property of
the material and the WEPL is a property of the individual proton.
PSD-1 PSD-2
Residual Energy-Range Detector
PSD-3 PSD-4
Patient
Proton
Figure 2.1: A schematic of an ideal proton CT system, redrawn from [22]. In this
figure, the residual range-energy detector is a detector capable of measuring either
the residual energy or range of the proton beam.
The design constraints in proton CT are set so that any uncertainty or ambi-
guity in measurement of the proton path or residual energy is minimal compared to
the statistical variations between protons [22]. These statistical variations arise from
the stochastic nature of proton interactions. Variations occur in the lateral position
of the beam at a given depth in the patient (lateral straggling), proton direction
at a given depth (angular straggling), energy at a given depth (energy straggling)
and the final proton range for a given initial proton energy (range straggling). A
combination of lateral straggling and angular straggling leads to a positional uncer-
tainty in the patient of the order of 1 mm when reconstructing proton paths. The
statistical variation in final proton range will be dependent on the initial energy
spread of the beam however can be considered to be around 1% of the proton range.
For a beam with a nominal energy of 200 MeV and an initial range of 260 mm in
water the range straggling will be around 3 mm. The magnitudes of both of these
uncertainties are likely to vary depending on the quality of the initial proton beam
as well as the specific patient geometry however these values provide an idea of the
limitations of proton CT.
There are further considerations when designing a proton CT system for clin-
ical use. Keeping the imaging time short reduces the total dose given to the patient
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as well as ensuring that use of the system can be realistically implemented into a
clinical workflow. This requires a system to be efficient in proton detection. Detec-
tors can be tuned to work optimally with knowledge of the specific time structure
of the proton beam, however this varies between accelerator modalities due to the
different methods of accelerating protons. Secondly, the size of the imaging field
of view must be considered. This is currently limited by the range of the proton
beam. Most proton therapy centers operate with a maximum beam energy of 200 -
250 MeV delivering between 26 - 38 cm range in water. Whilst this range may be
sufficient to image paediatric patients and the skull, the range is not high enough to
image areas such as an adult torso. Both of these design challenges would benefit
from consideration by accelerator physicists with interest in developing proton CT.
2.1.5 Current proton imaging systems
A small number of collaborations have been formed since the early 2000s to develop
proton CT systems and work on the associated challenges such as fast data acqui-
sition and non-linear image reconstruction. The most significant of these groups
include the collaboration between Loma Linda University and the University of
California Santa Cruz (LLU/UCSC) with California State University, Baylor Uni-
versity, Northern Illinois University and the University of Wollongong each making
contributions and the Italian PRIMA Collaboration.
The first proton imaging system in the modern era, used to reduce stop-
ping power uncertainties was a proton radiography system capable of taking planar
images at the Paul Scherrer Institue (PSI) in Switzerland. The system contains
2 tracking detectors either side of the image subject comprising scintillating fibres
and a plastic scintillator range telescope. The active area of the imaging device was
22.0 x 3.2 cm2. The system was used to optimise the HU to RSP conversion curve
by comparing the calculated WET through an animal patient with measured WET
from the radiography system for each proton path. By optimising the conversion
curve, the mean WET deviation was reduced from 3.6 mm to 0.4 mm, suggesting
that the modality could reduce a significant systematic error in the delivered proton
range if used at the treatment planning stage [39, 40].
The LLU/UCSC collaboration began work in 2005 with an initial study into
the electron density, and consequently stopping power, resolution of a potential pro-
ton CT system [33]. These studies showed that an accuracy of greater than 1%
should be possible for proton CT. The collaboration went on to build two proton
CT prototypes, namely the Phase II and Phase II instruments [29]. These proton
CT systems were constructed based on silicon strip detector (SSD) technology for
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individual proton tracking with scintillators providing the measurement of the resid-
ual energy of the beam. The tracking system of the Phase I system used two planes
of SSDs in an x-y orientation. Each SSD was 400 µm thick with a pitch of 228 µm.
The detectors were tiled to increase the field of view, however the x and y planes
were offset from each other to reduce the effect of the “dead zone” around the edge
of the sensor [41]. The energy measurement was performed by a calorimeter con-
taining CsI:Tl crystals readout by photodiodes. The system was slow, with a scan
time of several hours however did implement reconstructions taking advantage of the
proton most-likely paths. Artefacts arose in the produced images due to the gaps
between the SSDs, and the authors saw room for development in the calorimeter in
the Phase II system [42].
The Phase II system operates between 10-100 times faster than the Phase I
system and would be capable of imaging a human lead in less than 10 minutes [42].
The field of view of the system extends to approximately 8.8 cm x 35.0 cm where an
object can be scanned through the system. The SSDs were improved by sawing the
edges to minimise the “dead space” surrounding the detector such that they could be
tiled more effectively. The calorimeter was redesigned to become a novel segmented
energy-range detector, where 5 individual stages of a polystyrene-based scintillator,
each measuring 5.1 cm in depth, were individually read out by photomultiplier tubes.
Segmenting the scintillator reduced the dynamic range required on the readout
electronics to determine the residual energy of each proton with the polystyrene
material operating significantly faster than the CsI:Tl crystals used in the Phase I
scanner. The system was used to image a number of test phantoms as well as a
paediatric head phantom [43, 44], with reported results claiming to achieve WEPL
resolution close to the theoretical limit of 2.8 mm and RSP accuracy of better than
3% for most materials with many better than 1%.
The PRIMA collaboration demonstrated a prototype system with a field of
view of 5.0 x 5.0 cm2, comprising SSDs to track protons and a YAG:Ce scintillator-
based calorimeter to perform measurements of the residual proton energy. The
YAG:Ce scintillator features a significantly shorter decay time than the CSI:Tl scin-
tillator of the LLU/UCSC Phase I scanner and the SSD thickness was much lower
than the LLU/UCSC design (200 µm), potentially reducing scattering caused by
the detectors therefore improving the spatial resolution of the system [45]. Images
of a 2 cm diameter plastic phantom have been published with an electron density
resolution of 2.4% and a proposed PRIMA II scanner will increase the field-of-view
of the system and feature a redesigned DAQ with an event rate exceeding 1 MHz.
Another Italian group, AQUA, performed proton radiography of a small
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animal in 2013 [46]. The system used gas electron multiplier chambers as position
sensitive detectors, with a stack of 48 polyvinyl-toluene plastic scintillators each read
out by silicon photomultipliers providing the measurement of the residual range. The
system only tracks protons as they exit the image subject, therefore the system can
only assume linear proton paths through the image subject however this is sufficient
for radiography. The active area of the detector is quite large at 30 x 30 cm2. The
rate capability of the system is also competitive at 1 MHz.
Other notable efforts include the collaboration between Northern Illinois Uni-
versity and Fermilab (NIU/FNAL), who constructed a system comprising scintillat-
ing fibres as trackers, and a scintillating range counter to determine the residual
proton range [47]. Despite intending to use the system with a 200 MeV clinical
beam, issues with the instrumentation and funding expiration unfortunately meant
that the system wasn’t tested [29].
Most recently, a group comprising the University of Bergen, Bergen Univer-
sity College, Haukeland University Hospital and Utrecht University are planning
to develop a new proton CT system using CMOS monolithic active pixel sensors
(MAPS) [48]. The group have published results testing a calorimeter that is based
on the use of MAPS detectors, providing the opportunity to track multiple protons
in each frame whilst measuring their residual range. A new prototype system is
planned.
2.2 The PRaVDA Proton CT
The PRaVDA collaboration began in 2013, with the aim of designing and building a
completely solid-state proton CT system. The PRaVDA system comprises 4 position
sensitive detectors and a proton range detector, called the range telescope. The
system was designed to be used with the proton beam at the iThemba Laboratory for
Accelerator-Based Sciences (LABS), South Africa, a proton beam with a maximum
range of approximately 240 mm in water. The beam is produced by a cyclotron. The
beamline uses passive scattering to flatten the beam and generate a maximum beam
size with a diameter of 10 cm. For the PRaVDA proton CT work, a beam energy of
125 MeV delivering nominally 118 mm range in water was used. A photograph of
the PRaVDA proton CT system in place at iThemab LABS is shown in figure 2.2.
The PRaVDA system is novel in its application of silicon strip detectors
(SSDs) to measure the residual proton range. The system is based on fully solid-state
technology and also uses a novel reconstruction algorithm to reconstruct RSPs from
list-mode data provided by the detector system. A motivation for using solid-state
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Figure 2.2: Photograph of the PRaVDA proton CT system at iThemba LABS.
technology is the capability of the detector systems to resolve multiple individual
proton hits at a fast rate. One approach in proton CT is to use a scintillator-
based range-energy detector, however the method is rate-limited due to scintillator
relaxation time and issues with pulse shaping in the presence of multiple hits [42].
2.2.1 Tracker Units
The use of SSDs for application in PSDs is relatively commonplace amongst proton
CT instrumentation [22]. The devices are popular due to their excellent efficiency,
fast readout rate and low noise characteristics, whilst being radiation hard. SSDs are
one-dimensional detectors, therefore typically two perpendicular planes of detector
are used to obtain 2D positional information. The PRaVDA approach is novel in
proton CT in that the PRaVDA PSDs use three planes of 1D SSDs in each PSD,
also called the tracker units. The three detector planes are oriented at 60◦ to each
other known as x-u-v orientation and create an effective pixel. This arrangement
reduces ambiguities when reconstructing multiple protons hits in a single frame.
The ambiguity rate in the case of 30 hits per frame is around 8% when using x-u-v
orientation, compared to 100% in a 2 layer x-y orientation [49].
The strips in the PRaVDA SSDs are 4.8 cm long with a pitch of 90.8 µm,
providing an active area of 93 x 96 mm2 [50]. Each detector layer is 150 µm thick.
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Figure 2.3: Photograph of a PRaVDA tracker unit with the top cover removed.
The three planes of detector are attached to aluminium stiffeners and held in place
with locating posts. The top layer of the SSD stack is visible and two layers are
underneath.
Each detector comprises 2048 strips with 1024 read out by 8 ASICs on each side.
The readout cycle of the SSD detectors is synchronized with the RF signal
used in the cyclotron at iThemba LABS, such that the detectors are triggered at the
beam spill rate of 26 MHz. The SSD readout is performed by a custom ASIC that
records a time stamp and a strip address when a signal is detected over a tunable
threshold. The system allows two thresholds so that multiple hits per strip can be
identified. Data is read out from the ASIC at a rate of 104 MHz, allowing up to 4
channels to be read out per ASIC per readout cycle.
The four tracker units are arranged so that there are two located before the
patient and two afterwards. This arrangement allows the reconstruction of proton
vectors entering and exiting the patient. By synchronising the detectors to the
beam spill rate, protons from individual beam spills may be tracked across the four
detector units [24].
2.2.2 Range Telescope
The PRaVDA range telescope is a range measurement detector and uses 21 layers of
SSDs to measure residual proton range. Hits in the SSDs are registered along with a
timestamp derived from the beam clock so that 1D proton tracks can be constructed
oﬄine. By operating at a sufficiently low beam current, individual protons may be
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discriminated by their time stamps and their residual range is determined by the
number of detector layers the proton is tracked through before coming to a stop.
Each detector layer is separated from the next by absorber sheets of PMMA plastic
measuring 2.0 mm thick, designed to increase the WET of each layer. The WET of
the whole range telescope defines the maximum residual proton range that can be
determined by the system. This is the dynamic range.
In the current set up, a proton must travel be tracked to at least the third
layer of the range telescope in order to be considered as a candidate for use in
reconstruction. This means that the minimum residual proton range in water that
is detected is 3 times the WET of the detector layer. The detector layer comprises
150 µm of silicon and 2 mm of PMMA. The WET of a material is the material
thickness multiplied by its RSP. The RSP of PMMA is approximately 1.16 and the
RSP of silicon is approximately 2.15, giving each layer a WET of
WETlayer = (0.15 mm× 2.15) + (2 mm× 1.16) = 2.64 mm. (2.1)
From this, we can perform calculations of the dynamic range of the range
telescope. The theoretical minimum residual WET that is resolved by the range
telescope is approximately 7.9 mm. The theoretical maximum residual WET that
is measured is the total WET of the 21 detector layers and is calculated to be
55.4 mm. Interpolating the proton range-energy tables of PSTAR finds that these
residual ranges correspond to energies of approximately 28 to 84 MeV. The WEPL
of the proton is determined by subtracting the measured residual WET from the
initial range of the proton beam. For a proton beam with an initial range of 116.8
mm in water, after subtracting the WET of the detectors in the trackers, the system
is capable of resolving a theoretical maximum WEPL of 105.8 mm and a minimum
of 57.5 mm.
In practice, the dynamic range is evaluated through a conversion curve and
the last layer of the detector is used purely to reject tracks. If a proton in a track
hits the last layer we cannot determine whether the proton has stopped in the last
layer or exited the back of the range telescope, so if a hit is detected then the data
is rejected to prevent errors introduced by misassigning the incorrect WEPL value.
Therefore, this reduces the dynamic range of the detector.
Due to the finite lower limit on the resolvable WEPL, when imaging a phan-
tom a range compensator is used. The range compensator comprises a PMMA cube
measuring 81 mm on each side with a recess matching the exact size and shape of
the phantom being imaged. The idea of the compensator is to ensure that each
proton has a WEPL within the dynamic range of the detector. This is important
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for protons around the edge of the phantom with low WEPL that may otherwise
not be detected. The compensator is corrected for at the reconstruction stage.
The range resolution of the detector is also determined by the WET of each
layer. The WET of each layer acts to discretize a nominally continuous distribution
of measured proton WET. The WET resolution uncertainty of the range telescope
from the discretization is calculated using
σ∆ =
∆√
12
. (2.2)
where ∆ is the WET of one layer. This leads to theoretical WET resolution of ±0.5
mm. This corresponds to maximum error in the WEPL determination of 0.64%,
and meets the requirement that the uncertainty in detector should be lower than
the statistical uncertainty in the beam range.
Using sheets of different WET adjusts the dynamic range and the WET
resolution of the detector. Using absorber sheets with a higher WET, either with a
larger thickness or higher RSP, increases the dynamic range of the range telescope
whilst reducing the resolution and vice-versa if sheets with a lower WET are used,
therefore a compromise must be made.
As with the trackers, the detector readout cycle is synchronised with the
cyclotron beam clock and each proton track is discriminated by using time stamp
measurements and a strip address. This becomes less trivial in the range telescope
as the proton slows down. An assumption made at the design stage is that each
proton will reach the end of its range within one time stamp. At 26 MHz, this time
stamp is approximately 40 ns. However, as the protons decelerate they spend more
time travelling at a slower speed and hence may be in the detector for longer than a
single time stamp. This was accounted for in experiment by running phase sweeps
to find the optimal trigger point from the beam clock signal. The percentage of hits
correlated from the first PSD to the range telescope was evaluated at each trigger
point and the point that gave the maximum correlation was selected.
Initially, a CMOS monolithic active pixel sensor was proposed for use in
the PRaVDA range telescope [51]. The proposed design comprised two wafer-scale
sensors measuring approximately 9.6 cm x 4.8 cm, abutting along one edge to create
an active area of 9.6 cm x 9.6 cm. The pixelated nature of the sensor meant that
a large amount of protons could be detected in a single frame, compensating for
the sensor’s relatively slow readout speed ( kHz refresh rate). However, tracking
hits from multiple protons over many layers of pixel detectors proved problematic
when more than 10 protons were in a single frame. In addition, concerns over the
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radiation hardness of the CMOS sensor led the project to opt to use the same SSDs
as specified for the tracker units. Despite these concerns, there remains interest in
developing CMOS sensors for proton calorimetry and for proton CT [48, 52].
Calibration Curve
In order to use the PRaVDA range telescope as a range detector, a calibration is
performed so that the last layer that a proton hits in the range telescope is known
as a function of WEPL. The calibration curve was constructed by exposing the
range telescope to protons that have traveled through a known thickness of PMMA
calibration sheets placed at the isocentre of the proton CT system. The WET of
each PMMA sheet was measured experimentally, therefore the proton WEPL in
each calibration measurement is known. The distribution of proton last-layers is
then constructed. The mode last layer, where most of the protons stop, is recorded.
A linear fit is performed between the mode last layer and the WET of the PMMA
calibration sheets to determine the WEPL of each proton that has travelled through
as a function of the last-layer.
A linear fit is chosen because the total range in water of the proton should
be a linear combination of range in the PMMA and range in the range telescope.
The residual range should approximately be
WETsample = Rtotal −Rres = Rtotal − (L×WETlayer) (2.3)
where L is the last layer. A linear fit would provide a negative gradient with
a magnitude approximately equal to the WET of a single layer. By counting protons
arriving at each layer in a Monte Carlo simulation of the PRaVDA system, we are
able to confirm this theory. The intercept of the fit should be equal to the initial
range of the proton beam. In practice the magnitude of the gradient is slightly
lower than the WET of an individual layer. This appears to be an artefact in the
data collection in the experiment and could be due to noise hits in the detectors
being correlated unintentionally with proton hits. This has the effect of reducing
the effective WET of each initial layer, therefore reducing the dynamic range of the
range telescope.
As expected, the experimental fit is linear up until layer 21 at which point
the WET of the calibration material is too small to be resolved due to protons
escaping from the rear of the range telescope. Because the 21st layer is used to
reject proton tracks, we can calculate that the lowest WET able to be measured
by the range telescope is 66.2 mm, compared with the theoretical value of 60.1
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mm. The calibration curve is shown in figure 2.4, alongside results from a Monte
Carlo simulation and the theoretical calibration curve to show how the experimental
results diverge slightly from the theory.
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Figure 2.4: Range telescope calibration curve used in the proton CT scan. The
WET of the PMMA calibration sheets is determined in Chapter 3. The minimum
WET that can be resolved by the range telescope is 66.2 mm.
2.2.3 Data Acquisition
The raw data rate acquired by the PRaVDA system was approximately 9 GB/s. A
series of internal and external multiplexers transferred data via camera-link cables
to three PCs used to write binary files corresponding to data recorded in the strip
detector system and in the front and rear halves of the range telescope. Each PC
contained four solid-state hard drives writing data in a RAID0 striped array in order
24
to maximise the efficiency of the data acquisition system. The binary files were then
processed oﬄine to reconstruct the image.
2.2.4 Reconstruction
Before image reconstruction, raw binary files from the detector system are parsed
to identify tracks from raw hit information, both in the PSDs and in the range
telescope. The PSD reconstruction tracks individual protons by their time stamp
to generate the input and output vectors for each individual proton. 1D tracks in
the RT are made in the same way and are used to assign a WEPL to the associated
proton. This process generates information in a list-mode format, rather than 1D
profile conventionally used in image reconstruction.
The reconstruction method used by PRaVDA is a backproject-then-filter
(BPF) approach [53]. Whilst standard CT reconstruction is usually performed using
filtered back projection [54], BPF offers a number of advantages for proton CT. In
filtered back projection, a 1D line profile is constructed from ray projections through
a 2D object recorded in each slice. The 1D profile is convolved with a 1D filtering
kernel and backprojected through a 2D reconstruction matrix. This is repeated over
a number of angles to complete the reconstruction. Proton CT data differs from
x-ray CT data as instead of a line profile, the data is in a list-mode format. By
reordering the backprojection and filtering, the process removes the requirement of
having to bin the proton CT data into 1D profiles is order to reconstruct the image.
BPF is one of many novel reconstruction methods proposed for use in proton CT,
with many examples of algebraic and iterative reconstructions in the literature [55].
2.3 Chapter Summary
In this chapter, proton CT is introduced and the PRaVDA proton CT system is
discussed with particular attention paid to the resolution of the detector systems.
The PRaVDA system was used in the following body of work to image two phantoms.
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Chapter 3
Relative Stopping Power
measurements at iThemba
LABS
3.1 Introduction
In this chapter, a water tank dosimetry system is used to determine the range
in water of the proton beam at the iThemba Laboratory for Accelerator Based
Sciences (iThemba LABS), South Africa [56]. Various materials were inserted into
the beam path and the change in the measured proton range in water induced by
these materials was used to determine their water equivalent thickness (WET) and
hence their proton stopping power relative to water (RSP). These measurements
were performed during two experimental visits to iThemba LABS in May 2016 and
November 2016.
3.2 Test Materials
3.2.1 PMMA Calibration Sheets
The PRaVDA proton CT system uses a range-based detector to determine the range
of the proton beam after exiting the imaging subject, known as the residual range.
The calorimeter uses layers of silicon strip detectors separated by PMMA absorbers
synchronised with the cyclotron to measure how far each individual proton travels
through the absorber medium after exiting the imaging subject. From this residual
range, the water equivalent path length (WEPL) that the proton travelled through
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in the imaging subject can be determined.
WEPL = Rangetotal − Rangeresidual (3.1)
The residual range is determined by establishing the last layer in the range
telescope that the proton reaches. A calibration curve is then used to determine
the WEPL that the proton took. This calibration curve is produced by measuring
the range distribution of protons in the range telescope having travelled through
a known WET in the imaging medium. This is done by using varying thicknesses
of calibration material placed at the imaging isocentre. The calibration material
comprised a set of polymethyl methacrylate (PMMA) sheets covering a range of
thicknesses. The WET of the PMMA sheets must be determined a priori and this
is detailed in this chapter using the water tank. For clarification, the WET is a
property of a particular sample, the RSP is a property of the material and the
WEPL is a property of each individual proton path. Due to multiple Coulomb
scattering, the WEPL that the proton takes through a particular sample is larger
than the WET of the sample.
PMMA calibration sheets were used in the commissioning of the PRaVDA
range telescope. Each sheet measured 20 cm x 20 cm, with thicknesses of 1 mm, 2
mm, 5 mm, 10 mm and 50 mm. The sheets were manufactured by Carville plastics
and were annealed to ensure they were of uniform density. They were finished
with a machine polish to ensure the thickness was within a tolerance of ± 0.1 mm.
The sheets had a cut-out on either side so that they could be suspended by a jig
in the imaging isocentre. A schematic is shown in figure 3.1. The WET of each
sheet was determined, as well as the WET of a few combinations of sheets. The
calibration sheets were then used to provide a known WET at the imaging isocentre
such that the residual range in the calorimeter could be plotted against the WET
of the PMMA in order to construct a calibration curve.
3.2.2 Tissue Equivalent Materials
The accuracy of the proton CT system was validated by scanning a phantom con-
structed from PMMA containing five so-called tissue equivalent materials (TEMs).
TEMs are materials that are selected to replicate the x-ray absorption characteristics
of human tissues for radiotherapy dosimetry purposes [57]. These materials are well
characterised for use in x-ray dosimetry, however their proton RSPs are unknown.
Therefore, their RSPs also must be determined through WET measurements.
The tissues replicated by the TEMs were cortical bone (SB5), lung (LN10),
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Figure 3.1: A 2D schematic of the PMMA calibration sheet. The cutouts on either
side of the sheet allowed the sheet to be suspended in a jig and clamped using
threaded bolts.
adipose/fat (AP7), as well as water (WT1) and “average” bone (RB2) which is
designed to replicate bone incorporating the hard bone, spongiosa and marrow.
The materials were supplied by Leeds Test Objects in cylindrical rods measuring 5
cm in length and 1.5 cm in diameter. The rods were then cut into 1.5 cm lengths,
with one section being used for WET measurements and another being used in
the construction of a phantom. The phantom was constructed by arranging these
tissue equivalent materials in a cylindrical body made of PMMA, and was used to
evaluate the performance of the PRaVDA pCT system. The segments for use in
WET measurements are shown in figure 3.2. The material’s chemical compositions
are published online [58] and each sample was weighed and measured in order to
establish the mass density of the particular sample. These properties are shown in
table 3.1.
3.2.3 Water Tank
The water tank is a standard tool for dosimetry in radiotherapy. An ionisation
chamber on a movable stage samples the radiation field in the water from the delivery
equipment in 3-dimensions and allows the beam profile to be measured. For proton
therapy, the water tank is particularly useful for determining the range in water of
the proton beam from the 1D Bragg peak measured along the central axis. From
the Bragg peak, the energy and standard deviation of the beam can be determined.
The water tank at iThemba labs was manufactured by Scanditronix and
measures 645 mm wide (x-axis), 560 mm high (y-axis) and 675 mm long (z-axis),
with PMMA walls that are 14.6 mm thick. The direction of the proton beam is
parallel to the z-axis. A circular entrance window with a diameter of 125 mm, for
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Figure 3.2: The samples of tissue equivalent materials used to measure their RSPs
Material
Length
(mm)
Mass
Density
(g/cm3)
Elemental composition by mass (%)
H C N O Cl F Ca
WT1
(Water)
14.96 1.02 8.41 67.97 2.27 18.87 0.13 2.35
SB5
(Cort. Bone)
15.01 1.85 2.60 30.58 0.98 38.93 0.06 26.85
AP7
(Adipose)
14.97 0.97 8.36 69.14 2.36 16.93 0.14 3.07
RB2
(Rib Bone)
15.08 1.30 Mixture of SB5 (46.5%), WT1 (53.5%)
LN10
(Lung)
14.88 0.28 Composition as WT1
Table 3.1: Lengths, mass densities and nominal atomic compositions of the tissue
equivalent material samples. Elemental compositions taken from [58]
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measurements along the central axis, has been machined to an average thickness
of 3.48 mm to reduce perturbation of the beam. The data acquisition system is
calibrated so that the WET of the water tank wall is accounted for in the data
output. The data acquisition system reports an integer value of dose between 0 and
1000 and the x, y and z-coordinates of each measurement point.
The water tank ionisation chamber is cylindrical and has an active volume 3.0
mm high and a diameter of 1.9 mm. The Bragg Peak measurement routine moves
the ionisation chamber along the z-axis at the centre of the beam and integrates
the charge collected in the chamber over a 0.1 mm region as the chamber moves
towards the front of the water tank. The charge collected in the ionisation chamber
is divided by the charge collected in a reference ionisation chamber, upstream in
the beamline, to account for any fluctuations in the beam current. The dose value
reported has arbitrary units and is typically scaled such that the maximum dose
in the measurement is 1000. The chamber has been calibrated against a local,
secondary standard chamber to ensure a uniform and linear response.
3.3 Theory
The WET of a material describes the thickness of the water in which a proton beam
would lose the same amount of energy as in the material. Through proton range
measurements, the WET of a sample can be determined [59]. If the thickness of
the material is known, the RSP can be derived from the same measurements. The
procedure is as follows. A reference Bragg peak is recorded with no material in the
way of the beam. The material of interest is then placed in front of the water tank,
and a new Bragg peak is recorded. The proton range in water is determined for
both measurements, and the decrease in the proton range in water caused by the
material is recorded as the WET of the sample material.
The median proton range occurs where the dose deposited falls to 80% of
the maximum dose deposited, on the distal edge of the Bragg peak [7], referred to
here as R80. From this the WET, and thus the RSP can be determined using
RSP =
WETm
tm
=
R80,m −R80,w
tm
, (3.2)
where tm is the thickness of the material sample.
The uncertainty on the RSP is calculated in two steps. First the uncertainty
in the WET was calculated using
αWET =
√
(αR80,w)
2 + (αR80,m)
2 (3.3)
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then the uncertainty on the RSP is calculated using
αRSP = RSP ×
√
(
αWET
WET
)2 + (
αtm
tm
)2 (3.4)
By making multiple measurements of the WET, the RSP of each material
may be calculated by taking a weighted mean of all measurements, defined as
RSPmean =
∑
iwiRSPi∑
iwi
(3.5)
where the weighting w is the inverse of the squared uncertainty:
wi =
1
α2i
. (3.6)
The associated uncertainty on the weighted mean is then:
αRSP,mean =
(∑
i
1
α2i
)−1/2
(3.7)
3.4 Method
3.4.1 Reference Measurements
Reference measurements of the proton range were taken using the water tank prior
to any measurements using the sample materials, with the experimental set up
shown in 3.3. A second set of reference measurements was taken after the sample
measurements to ensure that the range of the proton beam remained stable. The
range of the Bragg peak is determined by the energy of the proton beam. The energy
of the beam reaching the water tank can be adjusted upstream in the beam nozzle
by inserting graphite wedge degraders into the beam path that reduce the energy of
the beam. The wedges comprise two triangular sections adjacent to each other to
provide a continuously variable thickness of absorber. Their position is defined by
a control system that moves the wedges appropriately so that the beam delivers a
nominal range in water. The nominal range in water set by the wedges refers to the
depth at which the Bragg peak reaches 50% of the maximum dose along the distal
edge.
In the first experiment (May 2016), all measurements were taken with a full
energy beam i.e. the wedge degrader system was not used. This provides a nominal
proton range in water of 240 mm. In the second experiment (November 2016),
measurements were taken using the full energy beam and two degraded beams. The
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Figure 3.3: Schematic of the water tank measurements, showing the set up for
the WET measurements of the PMMA calibration sheets and the tissue equivalent
material samples. The PMMA sample, the TEM sample and the collimator insert
all removed from the beamline to measure reference beams.
nominal range in water of these beams was 240 mm, 118 mm and 52 mm, roughly
corresponding to mean energies of 191 MeV, 125 MeV and 80 MeV at the point of
delivery. Reference ranges for each experiment and wedge setting were calculated by
taking the mean range of the pre-sample and post-sample beams with the standard
deviation as the uncertainty.
3.4.2 PMMA Calibration Sheets
In the first experiment, shown in figure 3.4, each PMMA sheet had its WET mea-
sured individually to check for uniformity between the sheets. An H-bridge measur-
ing 16 cm in length was inserted in front of the water tank. The H-bridge held a jig
comprising locating pins set in a square arrangement to ensure that each PMMA
sheet was held perpendicular to the beam. Each sheet was inserted into the jig and
nuts were used to hold the sheets in place. The individual sheets measured 50 mm,
10 mm, 5 mm, 2 mm and 1 mm.
In the second experiment, the WET of combinations of PMMA sheets was
measured, using the full range beam and the two degraded beam settings. The
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Figure 3.4: Photograph of a PMMA calibration sheet, 50 mm deep in the jig in
front of the water tank. The proton collimator is shown on the left-hand side.
combined thicknesses were 50 mm, 20 mm, 12 mm and 10 mm.
3.4.3 Tissue Equivalent Plastics
To measure the WET of the tissue equivalent materials, a brass collimator with
a circular aperture 15 mm in diameter was inserted into the end of the proton
beamline. The collimator is 60 mm deep and completely stops the proton beam,
such that the only protons that can pass must go through the aperture. The tissue
equivalent materials were then inserted into the aperture such that they were flush
with the front face. This is shown in figure 3.5. Any air gaps around the edge of
the tissue equivalent materials had a negligible effect on the range distribution of
protons along the central axis.
In the first experiment, each sample was measured with a nominal 240 mm
range in water beam. In the second experiment, the samples were first measured
with a nominal 240 mm range beam before using the wedge degraders to achieve a
118 mm range beam and a 52 mm range beam. A schematic of the experimental
set up is shown in figure 3.3.
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Figure 3.5: Photograph of the brass collimator with a 15 mm diameter tissue equiv-
alent material inserted into the aperture.
3.4.4 Determining uncertainties in the water tank measurements
The range at 80% of the dose maximum was determined through linear interpo-
lation of the measured data points. During the May 2016 experiment, the water
tank data acquisition software performed a smoothing routine to reduce noise on
the measurement prior to output. However, any range uncertainty due to the mea-
surement noise was not accounted for. In order to calculate the uncertainty on the
measurement, for the second experiment the automated smoothing and scaling was
disabled and replicated manually.
The smoothing routine used by the water tank is a moving least-squares fit
that fits a cubic spline over a window of 31 points. Whilst the smoothing algo-
rithm is proprietary and no further information was supplied by the manufacturers,
the description of the smoothing routine is comparable to a Savitzky-Golay filter.
Therefore, a Savitzky-Golay filter was applied to the raw dataset, comprising 41
Bragg peak measurements. Other filtering techniques were tested, such as a median
filter. A cubic spline fit was performed to the median-filtered data set however the
Savitzky-Golay filter outperformed the median filter by offering a lower root-mean-
square residual when comparing the filtered data-set to the raw dataset.
An example showing the filter on one Bragg peak measurement is shown in
figure 3.6. Residuals were calculated by subtracting the dose measurements of the
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Figure 3.6: Bragg Peak measurement showing raw data points and linear interpo-
lation of filtered data.
filtered data set from the raw data set, divided by the maximum dose measurement
at the Bragg peak. A Durbin-Watson test was performed on each Bragg peak
measurement from the November data set. The test evaluates whether the residuals
are normally distributed around zeros, and therefore a homoscedastic uncertainty
may be used. A homoscedastic uncertainty is one that is equal for each data point.
A value close to 2 indicates that the residuals are distributed normally [60]. The
mean statistic over the 41 Bragg peaks taken over the experiment was 2.2, suggesting
that a homoscedastic uncertainty can be applied.
The homoscedastic error bar is calculated by assuming that the filtered
dataset correctly describes the Bragg peak, and thus a chi-square test of the raw data
against the filtered data would yield a reduced chi-square statistic of 1. From this
assumption, the homoscedastic uncertainty is calculated as the root mean square
residual over the entire data set:
α2dose =
1
ν
∑
(yraw − yfiltered)2 (3.8)
where ν is the number of data points. The mean uncertainty on the dose was
calculated to be 2.24% of the dose maximum. This uncertainty was then applied
to all of the dose measurements made during the first experiment. The uncertainty
on the range was then calculated by considering the range at 82.24% of the dose
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Measurement R80 [mm]
Reference Beam 1 238.24± 0.05
Reference Beam 2 238.16± 0.05
Mean 238.20± 0.08
Table 3.2: Reference beam range measurements from May 2016. Reference beam 1
was taken prior to any sample measurements and reference beam 2 was taken after
the sample measurements were complete.
maximum and 77.76% of the dose maximum, accounting for scaling errors due to
the uncertainty. However, this uncertainty proved negligible compared to the bin
width of the measurement performed with the ionisation chamber, which was ±0.1
mm.
3.5 Results
3.5.1 Reference Beams
The ranges of reference beams for the experiment in May 2016 are given in table 3.2.
The range of the beam decreased by 0.08 mm, most likely due to a slight decrease
in the proton energy from the cyclotron, however this range difference is negligible
and well within the tolerance of the machine. Small changes in the energy of the
beam protons emitted from the cyclotron are expected and usually a multi-layer
Faraday cup (MLFC) is used to monitor these changes so that corrective action
may be taken.
During the experiment in November 2016, the range of the beam changed
more significantly over the course of the measurements. This is shown in table 3.3.
This was not accounted for during the experiment due to a fault with the MLFC,
and therefore introduces a more significant uncertainty into the reference range of
the beam. A simulation study suggested that a range increase of 0.6 mm would be
caused by a 0.15% increase in the energy of the protons ejected from the cyclotron
which is feasible over a long measurement period, hence the requirement for the
MLFC. The measurements can still be used in RSP calculation however we must
account for the range shift by using a larger uncertainty. It should also be considered
that the accuracy of proton CT relies on confidence in the range of the beam, as
the initial energy or range of the beam is set at calibration time. Therefore, there
is an uncertainty in the accuracy of proton CT due to uncertainty in the range of
the beam.
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Measurement
R80 (mm)
240 mm Beam 118 mm Beam 52 mm Beam
Reference Beam 1 238.49± 0.01 116.24± 0.01 50.33± 0.01
Reference Beam 2 239.14± 0.01 116.82± 0.03 51.16± 0.01
Mean 238.88± 0.33 116.59± 0.45 50.74± 0.54
Table 3.3: Reference beam ranges from the November 2016 experiment. 240 mm,
118 mm and 52 mm refer to the nominal R50 range of the beam, set by the wedges.
Reference beam 1 refers to measurements taken before to any sample measurements
and reference beam 2 refers to those taken after the sample measurements were
complete.
3.5.2 PMMA Calibration Sheets
The results of the RSP calculations for each measurement are shown in figure 3.7.
As is expected, the magnitude of the uncertainties scales with the size of the sample.
This is because the absolute uncertainty in the WETs and absolute uncertainty in
the material thicknesses are relatively similar for each sample and is uncorrelated to
the sample size. Therefore, for the smaller samples which also have a lower WET, the
relative uncertainty becomes much larger. The calculated uncertainty appropriately
accounts for most of the RSP results that sit either above or below the weighted
mean value in figure 3.7. The measurements from the May 2016 experiment suggest
a bias in the 2 mm calibration sheets as they appear to have a systematically lower
RSP than all other samples, however the November 2016 experiment shows this is
not the case when these five calibration sheets are combined. A possible explanation
for this systematic shift is a small energy drift in the cyclotron that was not measured
before correcting itself. Another explanation could be an error introduced in the
measurement due to range straggling due to the presence of small air gaps.
The reference beam measurements in November 2016 show good agreement
with those taken in May 2016 over the three beam energies used. The combinations
of PMMA sheets comprising more layers (5 x 2 mm, [5 x 2 mm] + [2 x 1 mm]), have
a higher measured RSP than a single 10 mm sheet of PMMA. A possible reason
for this is range straggling. The interfaces between the many sheets of PMMA will
have small air gaps that affect the energy distribution of propagated protons. A
larger spread in energies will affect the gradient of the distal edge of the Bragg peak
and affect the range measurement R80. For example, the measured Bragg peak for
the 240 mm beam with 5 x 2 mm sheets of PMMA has a measured R80 0.4 mm
lower than the R80 value for the single 10 mm sheet of PMMA in the November
experiment. This corresponds to a WET difference of 0.4 mm, which is 4% of the
physical thickness of the sample, hence the discrepancy on the reported RSP values.
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Figure 3.7: RSP results from the PMMA calibration sheets, acquired over two
experiments and using proton beams with 240 mm, 118 mm and 52 mm range in
waters. The horizontal lines show the uncertainty in each measurement (1σ) and
the red line shows the weighted mean result. The combined uncertainty is shown
with the two horizontal dashed lines.
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However, this range difference is well within the tolerance of the equipment hence
the weighted mean value is with the error bars for the majority of the measurements.
The weighted mean RSP over all the measurements is 1.157 ± 0.002, and
this is within the error bars of most of the measurement points. This value is also
in agreement with an RSP value calculated using the PSTAR database of proton
stopping powers [61]. At 100 MeV proton energy, the stopping power of PMMA
relative to water is given as 1.158.
3.5.3 Tissue Equivalent Materials
RSP measurements from both experiments are shown in figure 3.8. The first mea-
surement point in each plot is from the range measurements performed in May 2016,
with the other three points from the November 2016 measurements. The magnitude
of the error bars on each sample is related to the uncertainty in the range of the
reference beams.
With the exception of LN10 and SB5, each tissue equivalent material shows
an increased RSP with the 52 mm range beam. However, across the energy range
used energy dependence in the RSP values should not be evident. Furthermore,
reducing the energy of the beam should lower the RSP for material with mean
ionisation potentials lower than water. This suggests that a measurement error is
likely.
Over all of the material samples, the largest deviation from the weighted
mean value is the 52 mm range beam measurement of AP7, where the absolute RSP
difference is 0.028 RSP. Sources of this error would be tolerance on the position of
the wedge degraders, affecting the range of the beam by ±0.5mm, energy drift in
the accelerator and error in establishing the height of the Bragg peak in noisy data.
Each one of these is accounted for in the error bars and hence the error bars on each
measurement point overlap with the weighted mean value.
With the exception of LN10, the weighted mean RSP for each tissue equiv-
alent material was calculated with a precision of better than 0.64%, providing a
measurement that can be used as a benchmark for the PRaVDA proton CT system.
The numerical results are shown in table 3.4. The relative uncertainty on the RSP
of LN10 is 2.2%. This is because the absolute uncertainty on the WET of each of
the samples is comparable, however because the WET of LN10 is less than a third
of that of the next lowest WET sample (AP7), the relative uncertainty is larger. A
way of reducing this uncertainty and increasing the accuracy of the results would
be to use material samples with a larger thickness.
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Figure 3.8: RSP results from the tissue equivalent materials, acquired over two
experiments and using proton beams with 240 mm, 118 mm and 52 mm range in
waters. Each plot is centred on the weighted mean result, with the 1σ uncertainty
for each measurement shown. The top data point in each plot is from experiment
1, when the beam was more stable hence there is a lower uncertainty in the mea-
surement than in the next three points.
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Material RSPmean Uncertainty
PMMA 1.157 0.002
LN10 0.273 0.006
AP7 0.943 0.006
WT1 0.985 0.006
RB2 1.220 0.007
SB5 1.641 0.007
Table 3.4: RSPs calculated from the weighted mean of all measurements.
3.6 Conclusion
Measurements of the WET and RSP of a range of PMMA calibration sheets were
taken at iThemba LABS. The uncertainty in the RSP of the calibration sheets is a
source of uncertainty in the reconstructed RSPs from the proton CT system, so it
is important to keep the uncertainty low. The measured RSP of the PMMA sheets
was 1.157 ± 0.002. This value is in agreement with the RSP of PMMA calculated
using the PSTAR database [61]. The uncertainty in the RSP calibration sheets
corresponds to 0.17% of the weighted mean value. This value can then be used
when considering the uncertainty in the proton CT results.
The RSPs of the tissue equivalent inserts were calculated so that they can
be used to evaluate the accuracy of proton CT reconstructions from the PRaVDA
system. The values were calculated with an accuracy of better than 0.64% for each
material with the exception of LN10 where the low WET of the material means that
a similar absolute uncertainty in RSP value to the other TEMs leads to a relative
RSP uncertainty of 2.2%. This could be reduced by measuring the RSP of a sample
with a larger physical thickness.
The work done to evaluate the homoscedastic uncertainty on the dose mea-
surements will be developed further in the following chapter, where a chi-squared
test will be used to validate a Monte Carlo simulation with experiment.
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Chapter 4
X-ray CT to Proton Stopping
Power Conversion
4.1 Introduction
In order to compare x-ray CT and proton CT for use in proton therapy treatment
planning, the x-ray CT image must be converted from x-ray attenuation, measured
in Hounsfield Units (HU), to proton relative stopping powers (RSPs). In this chap-
ter, a HU to RSP conversion curve is produced using the stoichiometric method
proposed by Schneider [12]. This is done so that we can compare proton CT and
x-ray CT images of phantoms used later in this thesis.
The method, first proposed in 1996, is widely used in proton therapy treat-
ment planning [11] despite its well documented uncertainties [2]. Whilst some mod-
ifications to the Schneider method account for some of these uncertainties [62], the
Schneider method is used in other studies as well as in hospitals as a gold standard
method for converting HU to RSPs in single energy x-ray CT, so it is appropriate
to use it here [63].
The conversion curve generated in this chapter will be used to compare the
quantitative accuracy of x-ray CT in reproducing RSPs of tissue equivalent materials
in two phantoms, for comparative studies with proton CT.
4.2 Theory
The stoichiometric method for converting x-ray CT Hounsfield Units to proton stop-
ping powers was first proposed by Schneider in 1996 and has since proved to be the
most popular and commonly used conversion method for proton therapy treatment
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planning [12]. Schneider’s method consists of four steps:
1. Take an x-ray CT scan of a number of materials with known properties covering
the Hounsfield Unit range.
2. Plot the measured Hounsfield Units as a function of electron density and
perform a least-squares minimisation to fit the data and derive the relation-
ship between Hounsfield Units and electron density. This relationship will be
scanner-specific and should be performed on each x-ray CT scanner intended
for proton therapy treatment planning.
3. Using the fitted relationship found in step 2, calculate theoretical Hounsfield
Units for human tissues using tabulated tissue composition data such as those
listed in ICRU46 [64].
4. Calculate proton RSPs for the same human tissues using the Bethe-Bloch
formula and plot them against the theoretical Hounsfield Units. A piecewise
fit will then yield a Hounsfield Unit to RSP conversion curve.
4.2.1 Hounsfield Unit to Electron Density calibration
The Hounsfield Unit (HU), also known as a CT number, is defined as
HU =
〈µx〉 − 〈µw〉
〈µw〉 × 1000 (4.1)
where 〈µx〉 and 〈µw〉 are linear x-ray attenuation coefficients of the material
x and water respectively. This would mean that typically the Hounsfield Unit of air
is -1000, the Hounsfield Unit of water is 0 and for bone a Hounsfield Unit of up to
around 2000 could be expected. For the following work, scaled Hounsfield Units are
preferred where HUair = 0 and HUwater = 1000. This is defined as
HUscaled = HU + 1000 =
〈µx〉
〈µw〉 × 1000 (4.2)
In the energy range typically used for x-ray CT imaging (80-160 kV), x-
ray attenuation occurs through photoelectric absorption, coherent scattering and
incoherent scattering. The linear attenuation coefficient may be parameterised as
a sum of these components each with a different Z-dependence [65, 12]. These
components are represented by kph, kcoh and kKN , where KN is an abbreviation of
Klein-Nishina. The Klein-Nishina coefficient describes Compton scattering for x-ray
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energy photons. The scaled Hounsfield Unit becomes
HUscaled = ρe,rel
kphZˆ
3.62
eff + kcohZ˜
1.86
eff + kKNZeff
kphZˆ
3.62
water + kcohZ˜
1.86
water + kKNZwater
× 1000 (4.3)
where ρe,rel is the electron density of the material relative to water and Zeff ,
Zˆ and Z˜ are calculated using the Bragg additivity rule:
Zˆeff =
∑
iwiZ
3.62
i∑
i Z
3.62
i
(1/3.62)
, Z˜eff =
∑
iwiZ
1.86
i∑
i Z
1.86
i
(1/1.86)
, Zeff =
∑
iwiZi∑
i Zi
. (4.4)
Zeff is the effective Z-number of the material and wi is the fractional com-
position by weight of each element in the mixture.
A least-squared minimisation is used to find the values kph, kcoh and kKN
in equation 4.3 using the known electron density of the materials in the x-ray CT
scan and the scanned Hounsfield Units. These k-values are specific to the x-ray CT
scanner used and characterise the x-ray response of the CT scanner. Whilst they
may be calculated from the literature as they relate to the photoelectric, coherent
scattering and Klein-Nishina cross-sections, fitting to measurement accounts to the
specific characteristics of the x-ray spectrum from the particular CT scanner.
4.2.2 Calculated Hounsfield Units and stopping powers
Once the scanner specific parameters kph, kcoh and kKN are known, theoretical
Hounsfield Units for a set of reference tissues can be calculated. The reference
tissues used typically would come from ICRU46 [64], collating work from Woodard
and White [66, 67]. These tables provide nominal elemental compositions of human
tissues, as well as their mass densities and electron densities. Equation 4.3 is used
to calculate these theoretical Hounsfield Units.
As well as these theoretical HUs, RSPs are calculated for the same reference
materials using the simplified Bethe-Bloch formula:
RSPm = ρe,rel
(
ln 2mec
2β2
(1−β2)Im − β2
)(
ln 2mec
2β2
(1−β2)Iw − β2
) (4.5)
where ρe,rel is the relative electron density of the material m, Im and Iw are
the mean ionization potentials, or I-values, of the material and water respectively
and β is the velocity of the proton in units of c. This formula ignores the shell
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Table 4.1: Elemental I-values defined by the Seltzer-Berger rule.
Element, i Gaseous compounds (eV) Solids and liquids (eV)
H 19.2 19.2
C 70 81
N 82 82
O 97 106
F - 112
Cl - 180
All Others - 1.13× Ii
correction, density correction and Barkas corrections to the Bethe-Bloch formula.
However it is simple to calculate and is used by the majority of proton therapy
clinics [11].
The I-value of the material is calculated using Bragg additivity:
ln Im =
∑
i
wiZi
Ai
ln Ii∑
i
wiZi
Ai
(4.6)
where Ii is the I-value of the ith element in the mixture. To improve the
accuracy of Bragg additivity, the elemental I-values are modified in a methodology
proposed by Seltzer and Berger, adopting new I-values for use in solids and liquids
when composing compounds. This modification is summarised in table 4.1 [14].
4.2.3 Piecewise Fit
The calculated RSPs are plotted against theoretical Hounsfield Units and a piecewise
linear fit is then used to construct the conversion curve across the HU and density
range. Schneider originally did this by joining each point, however the piecewise
method suggested by O¨de´n et al [14] uses a series of fixed knot points to define
linear regions. Between the knot points, a linear fit is performed with the constraint
that each piecewise section must be contiguous.
4.3 Uncertainties in the Stopping Power Conversion
The uncertainties in the x-ray CT to proton stopping power conversion curve have
been studied and reported in the literature [2, 15]. Whilst some systematic uncer-
tainties can be reduced by generating several calibration curves for use on different
sizes of patient and specific to certain treatment sites, in clinical use there is a chance
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that the incorrect calibration curve may be selected. Therefore, it is safer to account
for these uncertainties and design treatment plans with them in consideration.
4.3.1 X-ray CT Artefacts
The quantitive accuracy of x-ray CT is sensitive to a number of factors such as the
size of the imaging subject, the number of x-rays used to generate the image and
artefacts caused by high density gradients.
The size of the imaging subject affects the quantitative accuracy of the con-
version due to beam hardening. The x-ray beam used to generate the image in a CT
scanner is polyenergetic, with a non-uniform spectral distribution around the mean
x-ray energy. As the x-rays propagate through the imaging subject, lower energy
components of the spectrum are absorbed and thus the mean energy of the x-ray
spectrum increases [62]. The linear attenuation coefficient of a material is energy-
dependent, and the energy-dependence is Z-dependent, meaning materials with a sig-
nificantly different atomic number to water will have a different energy-dependence
to water.. Therefore, it can be seen using equation 4.1 that the Hounsfield Unit
value will be affected [2].
The beam current describes the fluence x-rays propagating through the imag-
ing subject. At lower currents, the image reconstruction will be susceptible to Pois-
son noise. The amount of noise in the image is dependent on the size of the phantom
for a given current. This is made more complicated by beam current modulation.
Modern x-ray CT scanners will automatically reduce the beam current to reduce
the total dose delivered to the patient. A variable current range can be set, however
it is difficult to quantify exactly how the noise will manifest in each slice.
Interplay describes artefacts introduced by large variations in density in the
image. These large changes can cause ring or ripple artefacts that affect the quan-
titative accuracy of the Hounsfield Unit measurement [68]
Due to the complex nature of x-ray CT reconstruction, these artefacts are
difficult to account for from first principles. However, these uncertainties can be ac-
counted for empirically by analysing scans of different sized phantoms, using a fixed
beam current and by varying the position of the sample materials. The variation
in Hounsfield Units for each sample over the range of measurements can be used
to evaluate uncertainty in Hounsfield Unit measurements before they are converted
into stopping powers [2].
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4.3.2 X-ray HU Parameterisation
In the stoichiometric method, X-ray HU are parameterised as a function of the
effective Z numbers of a material and three k coefficients, as shown in equation
4.3 through a least-squares minimisation to determine kph, kcoh and kKN . In this
fit, some uncertainty is introduced. This can be evaluated by calculating residuals
between the measured HUs of the calibration materials and calculated HU for the
same materials using equation 4.3.
4.3.3 I-values
The I-value of a medium is claimed to be a major source of uncertainty in the
stoichiometric method [15], contributing up to a 1.5% uncertainty in the range of
the proton beam. However, this study negates the correlation of elemental I-value
uncertainties in both the sample material and water. Therefore, this uncertainty
estimate is slightly pessimistic [11].
The I-values of individual elements are used to calculate the I-values of hu-
man tissues used in the stoichiometric method. The choice of elemental I-values has
been covered by several authors [14, 11], as has the contribution of uncertainty in
the I-values to the RSP [2]. Yang et al found that when calculating RSPs using
formula 4.5, an uncertainty of ±10% in elemental I-values corresponds to uncertain-
ties in RSPs of 0.17%, 0.23% and 0.65% in the lung, soft tissue and bone regions
respectively. However, no direct measurements of the RSP were performed so the
accuracy of these values was not evaluated.
Doolan et al compared different sources of I-value data, as well as different
forms of the Bethe-Bloch formula to calculate RSPs of tissue equivalent materials
[11]. Using the Schneider RSP formula (equation 4.5) with I-values taken from ICRU
49, Doolan calculated an RMS error of 0.96% in stopping power between calculated
RSPs and directly measured RSPs. The largest error was -2.09%, seen in the lung
equivalent material LN-450.
4.3.4 Choice of materials in conversion curve
The materials used to define the conversion curve can influence the accuracy of the
curve when calculating the RSP of human tissue. A degeneracy in the conversion
curve occurs both close to water, and at higher Hounsfield Unit measurements.
Some plastics such as PTFE and Mylar have a disproportionately high RSP given
their HU and distort the accuracy of the curve. Conversely, some tissue substitutes
such as PVC and sulfur have a lower RSP given their HU. This potentially means
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that the conversion curve may perform more poorly for tissue equivalent materials
than for human tissues when converting x-ray HU to RSPs. For this reason, the
conversion curve used will be constructed using a combination of human tissues and
tissue equivalent materials.
4.3.5 Choice of proton beam energy
It is known that the Bethe-Bloch approach is inaccurate for proton energies below 1
MeV however at this point the proton range is small enough (< 0.03 mm in water)
that such errors are negligible [62]. More importantly, the RSP of the material may
vary across the energy range of the therapeutic proton beam. As the beam loses
energy in the material, the absolute stopping power of the material increases. If
this increase occurs at a different rate to the equivalent rate in water then the RSP
of the material becomes more strongly energy dependent. This occurs mainly in
materials with an effective atomic number away from water, such as bone. Yang et
al [2] report an uncertainty of upto 0.4% in RSP calculation due to not accounting
for the energy of the proton beam, however they note that the range calculation
was more accurate when using a proton energy of 100 MeV to calculate RSPs vs an
energy of 175 MeV.
4.4 Method
4.4.1 Scanning
Three phantoms were used to generate the conversion curve. The first was a
Gammex R©RMI electron density calibration phantom comprising a 35 cm cylinder
of Solid Water (TM) and cavities for 15 tissue equivalent inserts. Their compositions
are described in table 4.3. Each insert is 3 cm diameter and 6 cm in length. The
inserts were then individually scanned at the centre of a 20 cm diameter cylindrical
water chamber, and 85 mm diameter cylinder ring made from Perspex, referred to
as the donut phantom. Each phantom is shown in figure 4.1. The RMI phantom
allowed the effect of interplay to be quantified by moving the inserts around. The
range of diameters between the RMI phantom, water chamber and donut phantom
allowed the variation of HU measurements due to the beam hardening effect to the
quantified.
Each scan was performed at University Hospital Coventry and Warwickshire
using a modified Radical Brain protocol, with a 300 mA beam current and 120
kV mean energy. Beam current modulation was disabled. Hounsfield Units were
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Figure 4.1: Three calibration phantoms used to generate the conversion curve.
Shown are a) Gammex RMI Electron Density phantom, b) Donut phantom and
c) Water chamber. Phantoms B) and C) both use the inserts from the Gammex
RMI Electron Density phantom.
measured over 50 slices on a 300mm2 circular region of interest (ROI) around the
centre of the insert. A single slice from each phantom is shown in figure 4.2.
4.4.2 Parameterisation
A mean Hounsfield Unit measurement was calculated from the three phantoms. A
least-squares minimisation of equation 4.3 was performed using the mean Hounsfield
Units in order to determine the coefficients kph, kcoh and kKN using MATLAB.
Uncertainties on the parameterisation were taken by considering the root-mean-
square residual in the lung, soft tissue and bone regions individually [2].
4.4.3 Conversion Curve
Using the fitted k coefficients from the previous section, theoretical Hounsfield Units
were calculated for a) tissue equivalent materials listed in ICRU44 and b) tabulated
human tissues listed in ICRU46 using equation 4.3. As shown in Schneider’s paper
[12], the choice of materials can significantly affect the gradient of the conversion
curve in the bone region. Omitting Mylar, PVC and PTFE from the fit was con-
sidered however it was thought that for use with a plastic phantom, as long as they
did not significantly impact the gradient of the piecewise fit, it would be safer to
include them.
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Figure 4.2: X-ray CT images taken from the three calibration phantoms at Uni-
versity Hospital Coventry and Warwickshire used to generate the conversion curve.
Shown are a) Gammex RMI Electron Density phantom, b) Donut phantom and c)
Water chamber containing the cortical bone insert.
The RSPs of the materials were also calculated using equation 4.5, with their
I-values calculated using 4.6. The calculated Hounsfield Units and RSPs were then
fitted using a piecewise linear fit, performed using the Python library PWLF [69]
with knot points at HU = 0, 250, 880, 980, 1035, 1100, 1340 and 2500. These points
were selected by O¨de´n et al [14].
4.4.4 Uncertainties
Uncertainties in the scanning of the phantom and parameterisation of Hounsfield
Units manifest as uncertainties in HU measurement. Therefore, in order to consider
the effect that an uncertainty in the HU measurement may have on the RSP, it is
necessary to consider the first derivative of the conversion curve:
dRSP
RSP
=
dHU
HU
× HU
HU + b/a
(4.7)
where a, b are the slope and intercept of the conversion curve at the point
HU respectively. These uncertainties can then be combined with uncertainties in
the calculation of RSPs through an RMS sum. In this work, it was deemed that
uncertainties in the x-ray HU measurements and parameterisation formula could be
measured. Yang et al [2] studied comprehensively uncertainties in the stoichiometric
method therefore their values for RSP uncertainty due to energy dependence of
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Source
Uncertainty in converted RSP value (%)
0 <HU <800 800 <HU <1200 1200 <HU
CT scan size 3.44 0.65 3.88
Stoichiometric parame-
terisation
2.80 0.67 1.81
Elemental I-values* 0.96 0.96 0.96
Beam energy used to
calculate RSP*
0.2 0.2 0.4
Conversion Curve Fit 0.69 0.08 0.57
Total 4.59 1.80 4.44
Table 4.2: RSP uncertainties in the conversion of x-ray Hounsfield Units to RSPs.
Starred values are taken from the literature [2, 11].
the RSP calculation will be used, whilst Doolan’s [11] value of RMS error in RSP
calculation will be used as an uncertainty due to I-value calculation.
4.5 Results
The results from the x-ray CT scans of the RMI phantom, donut phantom and the
water chamber are shown in figure 4.3. The magnitude of the variation in HU mea-
surements due to phantom size increases with the electron density of the material.
The strong divergence in the measurement of materials with higher electron density,
into the bone region, is due to beam hardening. The tissue equivalent materials
in the bone region have a higher effective Z-number than water and consequently
their energy dependence of their x-ray attenuation is stronger than material in the
soft tissue region. The larger phantom had higher image noise resulting in a larger
standard deviation a given measurement, compared to the two smaller phantoms
however this is too small to be seen on the plot as an error bar. A mean Hounsfield
Unit measurements was calculated for each phantom. Normalised residuals for each
phantom compared to the mean result are shown in figure 4.4. Taking the same
approach as Yang et al [2], uncertainties in Hounsfield Units were calculated by
taking the RMS residual in the lung region, soft tissue region and bone region, cor-
responding to 0 to 800 HU, 800 to 1200 HU and > 1200 HU respectively. These
were 3.44%, 0.65% and 3.88% respectively. Varying the position of the inserts in
the RMI phantom resulted in a negligible change in the HU measurement so this
was not investigated further.
The mean Hounsfield Units were fitted with equation 4.3 to find the coeffi-
cients kph, kcoh and kKN . These values were -0.0006, 0.0001 and 2.1598 respectively.
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Figure 4.3: Hounsfield Units vs Electron Density for the three calibration phantoms
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Figure 4.4: Normalised residuals in HU measurements to mean Hounsfield Units
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Figure 4.5: Mean Hounsfield Units vs Theoretical Hounsfield Units, calculated
through parameterisation of equation 4.3
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Figure 4.6: Conversion curves calculated based on human tissues and tissue equiv-
alent materials. The materials labelled on the plot are significant outliers, however
they were included in the tissue equivalent material fit as their net effect on the fit
was minimal. The outliers were useful for defining uncertainties on the fit.
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Figure 4.7: HU to RSP conversion curve with 1σ uncertainty highlighted in blue,
calculated from the uncertainties evaluated in table 4.2.
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Figure 4.5 plots the measured HU units against values calculated using the fit and
can be used to evaluate the fit. The RMS residual was again evaluated in the lung,
soft tissue and bone regions. The RMS residuals were 2.80%, 0.67% and 1.81%
respectively.
RSPs and Hounsfield Units were then calculated for the reference set of body
tissues and tissue equivalent materials. A piecewise linear fit was performed to each
reference set using the Python library PWLF [69], with knot points at 0, 250, 880,
980, 1035, 1100, 1340 and 2500. This is shown in figure 4.6. It can be seen in the
bone region that there is a divergence between the human tissue fit and the tissue
equivalent material fit that manifests as an uncertainty in the final RSP conversion.
A piecewise fit considering all of the data points was then performed, to be used as
the conversion curve. This is shown in figures 4.6 and 4.7, with the total highlighted
in blue. A breakdown of the uncertainties is given in table 4.2.
Uncertainties in the RSP due to uncertainties in elemental I-values are taken
from [11], as they encompass uncertainties in the calculated RSP of tissue equivalent
materials. The uncertainty value due to the beam energy is taken from [2]. The
uncertainty in the conversion curve fit takes the RMS residual in the lung, soft tissue
and bone regions between the calculated RSP of each material in the piecewise fit,
and the RSP value of the fitted curve at each point.
The uncertainties shown in table 4.2 are comparable with those calculated
by [2], with the exception of the bone region. Yang reports an uncertainty value
of 0.5% in the stoichiometric parameterisation, however for the measurements here
the evaluated value of 2.17% is considerably larger.
It can be seen that even accounting for a relatively large uncertainty, the
conversion curve may perform poorly when converting HU to RSP of some materials
used as tissue substitution. The fit of the conversion curve also overestimates the
RSP of materials in the bone region. Optimisation of the knot points may improve
the fit however this is outside of the focus of this thesis. Furthermore, the relative
quantity of dense materials such as cortical bone in proton therapy treatment sites
is low compared to the quantity of soft tissue, therefore the RSP uncertainty in
the bone region is largely diluted when considering proton range uncertainty in a
therapeutic situation.
4.5.1 Evaluation
The conversion curve was used on an x-ray CT scan of the PRaVDA Bauble phan-
tom. The Bauble phantom contains five tissue equivalent plastic inserts and an
air cavity in a cast PMMA sphere with a radius of 75 mm. The inserts and their
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compositions are described in chapter 3. The phantom was scanned using the same
protocol as the calibration scans. Hounsfield Unit measurements were made using a
cylindrical ROI over 10 slices for each insert, and over 30 slices at the centre of the
phantom for PMMA, on each scan. A look-up table based on the conversion curve
was used to calculate the RSP of each insert and the result was plotted against the
RSP as measured in chapter 3. This is shown in figure 4.8.
The RSPs calculated using the conversion curve are over-estimated with re-
spect to the RSPs measured by the water tank. The RMS error on the measurements
is 6.7%, with a maximum error of 9.3%. The magnitude of the error in this partic-
ular example is much larger than we would expect to see in the clinic. For one, the
physical size of the phantom used to evaluate the conversion curve is very small and
hence the bone insert in particular is particularly sensitive to this size difference.
Any conversion curve used in the clinic would go through a more robust evaluation
and quality assurance tests to ensure it is suitable for use before treating patients.
However, because the focus of this thesis is on a non-optimised proton CT system,
we merely wanted to follow the appropriate steps to obtain an x-ray CT conversion
curve that is suitable for use with simple phantoms. One way in which we could
improve the accuracy in the conversion is to scan the Bauble phantom inside a water
chamber to increase beam hardening and obtain a HU measurement similar to the
average calibration conditions.
4.6 Conclusion
A study of the x-ray CT Hounsfield Unit to proton stopping power conversion process
yielded conversion curves for use in a comparison of the performance of x-ray CT
and proton CT on plastic phantoms. An evaluation of the curve demonstrated
pitfalls in the conversion of HU to RSPs when using tissue equivalent materials.
The relatively large systematic errors in the measurements are not covered by the
uncertainties accounted for when producing the conversion curve, hence proving the
need for a more robust system to obtain RSP measurements for proton therapy
treatment planning [2].
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Figure 4.8: RSPs of tissue equivalent materials taken from an x-ray CT scan of
the PRaVDA Bauble Phantom calculated using the stoichiometric method plotted
against RSPs for the same materials measured using a water tank.
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Chapter 5
Bauble Phantom CT:
Comparison of x-ray CT and
proton CT
5.1 Introduction
In this chapter, we present the first proton CT scan from the PRaVDA proton CT
instrument. The proton CT scan is of a phantom known as the Bauble phantom.
The phantom was designed to evaluate the accuracy of proton CT in reconstructing
RSPs. This proton CT scan is the first to be performed using a fully solid-state
system, with semiconductor detector technology being used in both the tracking
system and the range telescope. The data presented was acquired at iThemba
LABS in November 2016.
Two CT reconstructions of the proton CT dataset were performed, one as-
suming that the protons took linear paths, whilst the other accounts for multiple
Coulomb scattering inside the phantom by backprojecting through non-linear pro-
ton paths. Images are presented to qualitatively discuss the differences in image
quality between the proton CT reconstructions and a comparative x-ray CT scan.
Furthermore, artefacts in the proton CT images are explored and explanations as
to their causes are offered.
The accuracy of stopping power reconstruction in proton CT is analysed and
compared to both x-ray CT and measurements taken with the water tank. These
stopping power results are important in the context of proton therapy treatment
planning, where proton CT aims to reduce the uncertainty associated with calculated
proton range in order to reduce the planning margins in proton therapy.
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Finally, the ability of proton CT to accurately reproduce stopping powers is
compared with dual-energy x-ray CT (DECT) by performing theoretical calculations
to model range uncertainty. DECT effectively takes two CT scans using x-rays of
different energies. The energy-dependence of x-ray attenuation is exploited to pro-
vide more information about the Z-number of the material being imaged compared
top single energy x-ray CT. For this reason, there is a strong interest in using DECT
in proton therapy treatment planning and it should be considered as a competitor
to proton CT [70, 71]. A recent study modelled proton range uncertainty on images
generated using a number of DECT methods [63]. We perform a similar modelling
in order to compare with results with the literature for DECT and standard, single-
energy x-ray CT.
5.2 The Bauble Phantom
The Bauble phantom was constructed in order to evaluate the accuracy of proton
CT in RSP reconstruction. A spherical phantom body measuring 75 mm in diameter
was cast from two pieces of polymethylmethacrylate (PMMA), with vertical recesses
designed to contain rods of tissue equivalent materials to create inhomogeneities.
These materials were arranged to create a high contrast and low contrast section
of the phantom. These two sections contain materials with a broad range of RSPs
and a narrow range of RSPs respectively and represent two different challenges for
the CT modality: reproducing an image accurately with high gradients in stopping
power and accurately reproducing RSPs such that regions with small variations in
RSP can be distinguished. The high contrast region of the phantom contains air,
LN10 and SB5, whilst the low contrast region contains AP7, WT1, and RB2. These
tissue equivalent materials represent lung, cortical bone, adipose, water and rib bone
respectively. Their properties and RSPs were introduced and discussed in chapter
3. A cross-section of these two halves is shown in figure 5.1.
5.3 Proton CT Scan
The proton CT scan was completed using the PRaVDA proton CT system described
in chapter 3 at iThemba LABS in November 2016. A schematic is shown in figure
5.2. The phantom was placed on a rotational stage controlled by an encoded stepper
motor in order to precisely rotate the phantom in steps of 1 degree. A range com-
pensator was attached to the entrance window. The range compensator is a cube
of PMMA with a recessed spherical volume in the centre designed to match the
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Figure 5.1: A schematic of the PRaVDA Bauble phantom showing the high contrast
and low contrast regions respectively.
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Figure 5.2: A schematic of the PRaVDA proton CT system.
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spherical volume of the phantom. The range compensator is designed to reduce the
range of protons that would travel through the shallower segments of the phantom.
Without this compensator, the protons would escape the range telescope and their
residual energy cannot then be determined. The range compensator is corrected
for at the reconstruction stage. With knowledge of the trajectory of the incoming
proton, the water equivalent path length (WEPL) that the proton took through the
compensator can be determined and subtracted from the measured water equivalent
thickness (WET) determined in the range telescope.
The system captured proton data for 6 seconds for each angle, operating at
a beam current of around 500 pA, corresponding to approximately 2 million protons
per second. The total acquisition time was 18 minutes accounting for reinitialisation
of the sensors. Time stamps for each beam spill of the cyclotron were used to
discriminate individual protons. Cuts were applied to the data to consider 2 million
protons per angle that were tracked through the system and did not scatter out. Two
reconstructions were performed using a novel backproject-then-filter approach [53],
assuming linear and non-linear proton paths. The linear proton path reconstruction
assumes that protons have travelled through straight lines through the phantom, and
the non-linear proton path reconstruction accounts for multiple Coulomb scattering.
Small deviations to the proton path are calculated by calculating linear deviations
based on a cubic-spline path.
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5.4 Comparison of x-ray CT and proton CT
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Figure 5.3: A comparison of CT images from proton CT and x-ray CT scans of
the Bauble phantom. The labels on the x-ray CT image correspond to the circular
inhomogeneities visible in each section of the phantom.
5.4.1 Image Quality
Images have been selected from two proton CT reconstructions, linear proton path
and non-linear proton path, and an x-ray CT reconstruction, showing the low con-
trast and high contrast halves on the phantom. The proton CT images are an
average of three 1 mm slices, giving an effective slice thickness of 3 mm. The x-ray
CT image has a slice thickness of 2.5 mm. The proton CT images have pixel sizes
of 1mm2 and the x-ray CT scan was rebinned from an image with pixel sizes of
0.46mm to pixel sizes of 1mm2.
Qualitatively, the non-linear path proton CT reconstruction appears to have
sharper edges around the periphery of the phantom body when compared with
the linear path reconstruction. However the x-ray CT image is superior in terms
of image quality with significantly less noise than both of the proton CT scans.
In the proton CT reconstructions, a streak artefact is visible in the high contrast
region of the phantom, between the two low-density inhomogeneities LN10 and air.
This artefact increases the reconstructed RSP of the PMMA body between the two
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inserts. A second artefact in the proton CT scans that is less immediately obvious
on the image is a darker ring at the exterior of the phantom. This ring artefact
causes a reduced RSP measurement in this region. These artefacts both become
more apparent when considering cross-sections through the reconstructed images.
5.4.2 Cross-Sections
1) 2)
3)
P
a)
Figure 5.4: Schematic illustrating the position and orientation of cross sections dis-
cussed in the following figures. The cross sections labelled 1, 2 and 3 highlighted
in red were used to compare imaging modalities, whilst the cross section a) high-
lighted in blue was used to highlight the streak artefact. The box P represents a 1D
projection taken through the image.
Cross sectional profiles have been taken across three lines in the high contrast and
low contrast regions. Each profile crosses two inhomogeneities and shows how the
reconstructed RSP varies across the image. For illustrative purposes, the orientation
of the cross-sectional profiles is shown in figure 5.4, labelled 1), 2) and 3). These
profiles shown are averaged over a 1 cm slice thickness and are shown in figures 5.5
and 5.6. The expected RSP value for the relevant materials is also plotted alongside
the profiles.
In the low contrast region, the x-ray CT image systematically overestimates
the RSPs. This is expected, considering the results in chapter 4 where the converted
RSPs of the insert materials were slightly overestimated through the HU to RSP
conversion process. However, compared to both proton CT modalities, x-ray CT
shows superior accuracy at the edges of the phantom, demonstrating the effect of the
proton CT ring artefact. The linear and non-linear reconstructions appear to be very
similar in performance. It was considered that a reason for the poor performance
at edges could be the size of the image reconstruction matrix. The x-ray CT image
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was reconstructed with pixels of size 0.46 mm, compared with 1 mm pixels in the
proton CT. However, the ring artefact seems to be more significant than the size
of the reconstruction matrix. This is demonstrable by comparing the penumbra
measurements.
The penumbra at the edge of the phantom is calculated firstly by considering
the distance at which the profile falls from 80% of its maximum value to 20% of its
maximum value at the edges of the phantom. Secondly the penumbra from 90% to
10% is evaluated. This is calculated as an average of all three profiles. The proton
CT penumbra from 80% to 20% is 2.41 mm for the linear proton CT reconstruction,
2.45 mm for the non-linear proton CT reconstruction and 2.06 mm for the x-ray
CT reconstruction. The penumbra from 90% to 10% is 5.62 mm for linear path
proton CT, 4.94 mm for non-linear path proton CT and 3.60 mm for x-ray CT. The
most significant difference in the penumbra between proton CT and x-ray CT arises
when considering the larger penumbra, suggesting that the edge artefact is more
significant than the inherent spatial resolution of the image.
In the high contrast region, it can be seen that both proton CT methods
reconstruct the stopping power of SB5 more accurately than x-ray CT. However,
in the low density regions (LN10, Air), proton CT fails to reconstruct the stopping
powers accurately. In the cross section containing both the air and LN10 insert, the
streak artefact mentioned above can be seen to distort the reconstructed stopping
power of PMMA. The inability of the reconstruction to correctly reproduce low
stopping powers particularly in the air inhomogeneity suggests that the ability of the
range telescope to resolve high energy protons impacts on the image reconstruction.
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Figure 5.5: Three cross sections taken through the CT images in the low contrast
region of the phantom taken at 120 degrees with respect to each other, such that each
cross section intersects two inhomogeneities. These cross sections are illustrated in
figure 5.4.
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Figure 5.6: Three cross sections taken through the CT images in the low contrast
region of the phantom taken at 120 degrees with respect to each other, such that each
cross section intersects two inhomogeneities. These cross sections are illustrated in
figure 5.4.
The cross section shown in figure 5.7 is taken through a single 1 mm slice
at the centre of the phantom, corresponding to a region of homogeneous PMMA.
Other than the large penumbra seen at the edge of the profile, no significant features
or artefacts can be seen in this slice.
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Figure 5.7: A cross section through a homogeneous region of the Bauble phantom.
5.4.3 Artefacts
Condsidering the cross-sections shown previously provides evidence that the arte-
facts in the proton CT images may significantly impair the ability of proton CT to
accurately reconstruct RSP. By considering a 1D profile through the reconstructed
image, labelled as ‘P’ in figure 5.4, an explanation as to the cause of each artefact
is offered. The profile was made by rotating the image so that the centres of the
LN10 and Air inserts were aligned parallel with x-axis of the pixel matrix, and the
RSPs in each pixel were summed along this axis. This projection provides the water
equivalent thickness along each row of pixels. An ideal 1D profile was also modelled
by creating a matrix of true RSP values from the known geometry of the phantom.
Comparison of the experimental and modelled profiles will follow.
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Figure 5.8: Proton CT cross-section through the high contrast region of the Bauble
phantom. This profile is shown in blue in figure 5.4.
The streak artefact appears in both the linear and non-linear path reconstruction in
the high contrast region, seen in figure 5.3. A 1D slice through the phantom, labelled
in figure 5.4 as a), is shown in figure 5.8. This slice shows the features of the streak
artefact through the PMMA body. Where the RSP value should be uniform, the
streak is a peak in value with a trough at each side. The streak artefact is parallel
with protons paths that have been reconstructed through both the LN10 and Air
insert, suggesting that these two low-density inserts may be causing the artefact.
A simulated 1D projection of the profile is shown in figure 5.9, alongside
a 1D projection from the linear path reconstruction. A radially varying offset to
replicate the range compensator has been added to each profile, therefore the profiles
should be relatively flat except for the presence of inhomogeneities. The total water
equivalent thickness (WET) of the range compensator and the homogeneous region
of the phantom is 93.6 mm, and the modelled profile shows this. The two features in
the profile show where the proton path intersects the LN10 and Air inhomogeneities
and the SB5 inhomogeneity. Where the protons have travelled through both the
LN10 and Air inserts, the WET that the proton travels through reaches a minimum
of 63 mm. It is at this point that the streak artefact manifests in the 1D profile
through the reconstructed image. Comparing the model profile with the image
profile suggests that the signal or data used to reconstruct the image is clipped. This
could be caused by the range telescope. For now we are neglecting the approximately
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4 mm offset between the modelled profile and the reconstructed profile.
The range telescope resolves the WEPL of each proton has travelled through
by measuring the range of protons after the phantom. This WEPL is used in the
reconstruction and is obtained through a conversion curve. The WEPL of the proton
tells us the WET of the material that has been traversed. As shown in chapter 2,
there is a limit to the minimum WET that the range telescope can resolve, as
higher energy protons which have gone through a lower WET will continue past
the end of the range telescope. Hence, the measured WET will be higher than the
true value, explaining why the WET signal may be clipped. The point at which
the range telescope can no longer resolve the WET is marked on the plot. This
minimum is 68.2 mm, meaning that the measured WET through the two low RSP
inhomogeneities is outside the dynamic range of the range telescope. During the
reconstruction, as the backprojection algorithm combines well-conditioned WET
profiles at alternative angles with the clipped WET information, a streak artefact
is formed.
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Figure 5.9: Modelled 1D projection through the phantom at location P, as shown
in 5.4, compared against the same 1D projection through the reconstructed image.
Ring Artefact
The effects of the ring artefact are visible in figures 5.5 and 5.6, where the proton
CT reconstructions underestimate the RSP of PMMA at the edges of the phantom
compared to x-ray CT. Over a radius of approximately 10 mm at the edge of the
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phantom, the mean RSP averages 0.97, compared to an expected value of 1.156.
When summing the WET through the centre of the phantom projection, this corre-
sponds to an underestimation of the WET of approximately 20mm × 0.1860. This
WET underestimation is 3.7 mm, and would explain the offset between the expected
profile and the image profile in the previous section. The cause of this artefact is
less trivial than the previous artefact however a proposed explanation is that the
compensator was misaligned to the phantom during the experiment as discussed
below.
Whilst modelling the expected 1D profile, the compensator correction was
shifted by 0.5 mm to investigate the effects of possible collimator misalignment.
This can be seen in figure 5.10. The chosen value was arbitrary however some new
characteristics were introduced into the expected profile that correspond to those
seen in the image profile. The peak and trough at the extremities of the phantom
edges became larger, and the 1D profile became sloped. In this figure, an offset has
also been added to the image projection to account for the ring artefact at the edges
of the phantom. The profiles now look much more similar. Whilst determining the
exact misalignment is outside of the scope of this work, there is reason to believe that
this could be corrected by altering the compensator correction at the reconstruction
stage.
At this point it is also worth highlighting that when the WET is corrected
for the ring artefacts, the evidence for the clipped WET signal becomes much more
clear. This artefact exists in the data and it is not clear how to correct for this
therefore we must avoid this clipping during experiment. This most likely would
require an improved detector system, or at the very least further optimisation of the
current range telescope. In the novel reconstruction algorithm used, 1D profiles are
not calculated prior to reconstruction as the proton CT data is in a list-mode format
[53]. Computing the 1D profiles from the initial raw data set is computationally
expensive. However, if the profiles were to be constructed it may be possible to
correct for the clipped data by performing an interpolation between the points on the
profile where the projection crosses the WET threshold, although the quantitative
accuracy could not be guaranteed.
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Figure 5.10: Modelled 1D projection through the phantom at location P, as shown
in 5.4. The modelled projection was also modified by shifting the compensator
correction by 0.5 mm to see the effect. The original 1D projection of the image is
also shown with and without a WET correction, applied to counter the loss of WET
across the profile due to the ring artefact.
5.4.4 Stopping power results
Mean stopping powers for each material were determined by segmenting slices of
the proton CT image into circular regions in MATLAB using a Hough transform
function from the MATLAB File Exchange [72]. A total of 28 slices were used,
comprising 14 mm depth in the high contrast and low contrast segments of the
phantom. These were selected to neglect any partial volume effects occurring at
the ends of the inhomogeneities. A first Hough transform detected the radii of
the spherical PMMA in each slice, and a second Hough transform determined the
centres and radii of the inhomogeneities. Masks were then created for each material
in the dataset, with 1 mm subtracted from the diameter of the inhomogeneities to
remove the influence of partial volume effects, where a geometric boundary crosses
the pixel, on the results. A further 5 mm was omitted from the edge of the PMMA
to neglect the influence of the compensator misalignment on the results. A total of
89176 pixels were considered for PMMA and 1918 pixels for each inhomogeneity.
The mean stopping power and the standard deviation was recorded for each
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Figure 5.11: RSP measurements from different CT modalities compared to RSPs
calculated using water tank proton range measurements.
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material. Their results are summarised in table 5.1. With the exception of LN10
and Air, the reconstructed RSP of the materials was within 1.3 % of the value
measured by the water tank. The reconstructed stopping power values of LN10
had an absolute error of 0.039 and 0.027 for linear and non-linear proton paths
respectively. In 5 cm of LN10, this RSP error would correspond to a proton range-
in-water error of 1.95 mm and 1.35 mm respectively for linear and non-linear path
reconstructions.
RSP distributions from the non-linear path reconstruction are shown in figure
5.12. The bin width of the histograms are set to be 0.02 RSP, with the axes limits to
be the mean value +/- 4 times the standard deviation. The stopping power values
from the materials in the high contrast region of the phantom (LN10, SB5) have a
much larger standard deviation on their values than those in the low contrast region.
The distributions appear to be less Gaussian, with a tail on the left hand side of the
PMMA and SB5 distributions. This is caused by the presence of the streak artefact
discussed in the previous section.
The mean stopping powers as measured by proton CT are plotted in figure
5.11, alongside the RSPs measured by the x-ray CT. Both the non-linear and linear
path reconstructions of the proton CT image outperformed the x-ray CT in terms
of accurately reproducing RSPs for the inhomogeneities. Whilst the linear path
proton CT reconstruction was marginally more accurate than the non-linear path
proton CT reconstruction for the AP6, WT1 and RB2 inserts, in PMMA, LN10 and
SB5 the non-linear path reconstruction was significantly better than the linear path
reconstruction. The significant difference in density between LN10, PMMA and SB5
in the high contrast segment of the phantom would introduce more proton scatter,
hence the non-linear path reconstruction deals with this better than the linear-path
reconstruction.
A fit to test the linearity of each proton CT reconstruction method was per-
formed. The fit was constrained so that the function passed through the origin,
yielding a function of the form RSPpCT = mRSPWaterTank. The gradients of the
fit were 0.992± 0.017 and 0.999± 0.012 for the linear path and non-linear path re-
constructions respectively, suggesting that both fits were linear within one standard
deviation and reinforcing the fact that the non-linear path reconstruction is slightly
superior in the reconstruction of accurate RSPs.
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Material True RSP
pCT - linear paths pCT - non-linear paths
RSP SD % error RSP SD % error
Air 0.001 0.100 0.133 -* 0.084 0.132 -*
LN10 0.272 0.311 0.096 14.3% 0.299 0.090 9.9%
AP6 0.942 0.951 0.025 0.96% 0.952 0.026 1.1%
WT1 0.986 0.996 0.025 1.0% 0..999 0.025 1.3%
PMMA 1.156 1.14 0.044 -1.4% 1.147 0.042 -0.8%
RB2 1.219 1.226 0.023 0.6% 1.233 0.022 1.1%
SB5 1.624 1.598 0.043 -1.6% 1.620 0.034 -0.2%
Table 5.1: RSP results for the different materials, taken from the two proton CT
reconstructions. The evaluated error is the relative difference to the RSP of the
material as measured by the water tank. It was not deemed appropriate to evaluate
this error for the air cavity because the RSP of air is so small that any deviation
from this value is an extremely large percentage.
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Figure 5.12: Distributions of voxel RSP values for each material in the phantom.
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5.4.5 Range uncertainty calculation
The effect of proton CT accuracy on proton range uncertainty was considered next
by following the method of Ba¨r et al [63].
Proton range uncertainty in this context refers to confidence in the known
proton range. The range uncertainty will be affected by systematic errors in the
reconstructed stopping power, and also by random error seen in the distributions
of RSPs, for example caused by noise in homogeneous regions. In order to estimate
range uncertainty, the RSP errors on each voxel were used to resample a model of a
proton depth-dose curve used to calculate proton range. Using this result, the effect
of RSP errors in proton therapy treatment planning can be explored.
The depth-dose curve is represented as a series of 1 mm pixels, where each 1
mm step represents a voxel of water with an RSP value of 1 and WET of 1 mm. A
random RSP error is then applied to each 1 mm step, based on a probability density
function of RSP errors calculated from the CT image. For example, if a 1% error is
sampled then the RSP of the voxel will become 1.01 with a WET of 1.01 mm. This
is repeated along all of the voxels until the total WET along the path is equal to
the original range of the beam. The difference between the physical thickness and
the water equivalent thickness is then the range error. By repeating many times, a
distribution of range errors is constructed.
Both the linear and non-linear path proton CT reconstructions were imported
into MATLAB. The RSPs in each voxel were measured in the same way as the
previous section, with the values shown in figure 5.12. The relative error in each
voxel was calculated by subtracting the RSPs measured by the water tank from the
voxel RSP values, and dividing by the water tank RSP value, giving a percentage
error shown in figure 5.13. Figure 5.14 shows the distribution of RSPs in the image
over i) the whole phantom and ii) the phantom neglecting RSP errors in the high
contrast PMMA region, where the streak artefacts described previously affected the
quantitative accuracy of the result. The reason for this omission is that this artefact
could be removed with a range telescope with a larger dynamic range and it is not
an inherent property of the proton CT imaging modality. We opted to include the
RSP errors from our bone tissue equivalent materials as well as the soft tissue-like
materials in the PDFs to increase the number of samples in our dataset.
The range error calculation was performed with nominal proton ranges of 30
to 350 mm range in water in 10 mm steps. At each nominal range, the depth-dose
curve was recalculated 106 times and the range error recorded for each calculation.
The results from each range error calculation produce a Gaussian distribution at
each range value. The mean of the distribution informs us of any systematic uncer-
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of RSP errors over all of the voxels, and also when the PMMA voxels in the high-
contrast region are omitted.
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tainty in the reconstructed RSP values and the standard deviation informs the range
uncertainty at each point. The mean values and standard deviations are plotted in
figure 5.15, with an average value over all of the ranges given in table 5.2.
The linear path reconstruction, including all of the PMMA voxels, has the
largest systematic bias in all of the results with a mean range error of 1.31 %,
suggesting that the proton CT image underestimates the RSP in most voxels. This
range error is reduced to 0.67% if the high contrast PMMA region, where the streak
artefact exists, is omitted.
The non-linear path reconstruction including all of the PMMA voxels has a
reduced range error compared to the linear path reconstruction. For the data set
we have, the inherent bias in the result is reduced by more than 50%. This result
is comparable with the linear path result where the artefacted PMMA region is ex-
cluded. Omitting the artefacted region with the non-linear reconstruction produces
a range error of 0.02% with a maximum range uncertainty of 0.92%, significantly
reducing the bias in the result.
RSP error PDF Mean Range Error Max Range Uncertainty
Linear Path 1.31% 1.42 %
Linear Path, exc.
streak artefact
0.67% 1.07 %
Non-linear path 0.61% 1.29 %
Non-linear Path, exc.
streak artefact
0.02% 0.92 %
Table 5.2: Evaluated range errors and range uncertainties based on PDFs of RSP
errors in the proton CT images. Results excluding high contrast PMMA refer to
PDFs made that exclude parts of the proton CT reconstructions where imaging
artefacts affect the quantitative RSP value.
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Figure 5.15: Estimated range uncertainty based on resampling of depth-dose curves
using RSP error data from the proton CT image.
Figure 5.16: Estimated range error results in soft tissue for single energy and dual
energy x-ray CT, reproduced with permission from [63]. Low noise and high noise
refer to artificial Gaussian noise added to the reconstructed simulated images, in an
effort to replicate the noise conditions seen in experiment.
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5.5 Discussion
These first results from the prototype proton CT system designed and built by
PRaVDA are promising, however they must be considered in the wider context of
imaging for proton therapy. Much research has taken place to improve the accuracy
of RSP reconstruction, with other proton CT collaborations reporting results with
more clinical relevance. As well as proton CT, simulated and experimental studies
have shown that dual-energy x-ray CT (DECT) can also deliver reduced stopping
power errors compared to standard, single energy x-ray CT (SECT). Furthermore,
work with proton radiography has shown that HU to RSP conversion curves can be
optimised to reduce stopping power errors, and a number of in-vivo range verification
techniques are being developed to monitor the range of the treatment beam after
delivery.
In recent years, significant effort has gone into developing DECT as an imag-
ing modality for proton therapy. The equipment required to perform DECT scans
is already available in the clinic so many of the technical challenges associated with
developing the imaging equipment have already been passed. Recent work by Ba¨r
et al demonstrates the ability of DECT to improve the accuracy of RSP estimation
and a reduction in range uncertainty associated with proton CT [63, 16]. In these
two publications, the authors show simulated results from a humanoid phantom,
and experimental measurements using biological tissue.
Ba¨r et al demonstrate the potential for DECT to reduce range uncertainty
compared to single energy x-ray CT (SECT), as shown in figure 5.16. This figure
shows the range uncertainty associated with the SECT and DECT in soft tissues,
calculated as a function of range error on simulated SECT and DECT scans. Each
result is presented without noise and with Gaussian noise applied onto the x-ray CT
dataset prior to conversion to proton stopping powers so that the effect of image
noise on range uncertainty is also considered. This is important because noise is
currently a limiting factor in DECT. In a DECT scan, essentially the patient would
have two x-ray CT scans, so to reduce the imaging dose given to the patient the beam
current is reduced thus increasing image noise. What is noticeable in figure 5.16 is
that in the absence of noise, DECT offers the potential to improve on SECT results
primarily through reducing range error. However when noise is applied, the DECT
method offers little benefit over SECT when purely considering RSP accuracy. There
is a suggestion though that the extra data derived from the DECT scan would allow
the derivation of specific interaction cross-sections for the object being imaged [73].
These cross-sections would increase the accuracy of proton therapy by allowing
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accurate Monte Carlo treatment planning to take place.
Comparing the results of Ba¨r et al with the range uncertainty results pre-
sented in this chapter suggest that whilst noise persists in DECT, there is still a
need for proton CT. Whilst SECT outperforms DECT and proton CT in terms of
the range uncertainty, the range error in our proton CT scan is lowest compared to
SECT and DECT.
We now discuss our results in context with an alternative proton CT system.
The LLU/SCSC Collaboration recently published work on their Phase II proton
CT scanner. Their scanner uses silicon strip detectors as trackers, similar to the
PRaVDA instrument however their energy measurements are performed using a
scintillator-based range telescope [74, 42]. Results were presented demonstrating
the ability of their system to accurately resolve stopping powers in a Somatom
calibration phantom, a cylindrical phantom containing cylindrical rods of plastic
materials of varying stopping powers. Due to the tiling of the silicon trackers,
the imaging area of the LLU/UCSC Collaboration scanner (40 x 10 cm) is much
larger than the PRaVDA proton CT system. As a result, a full size calibration
phantom could be imaged. The group report an accuracy of better than 3% in
reproducing the stopping powers of various calibration plastics [43]. Performing a
linear fit of reconstructed stopping powers vs expected stopping powers yields a
gradient of 0.994 with a standard deviation of 0.009, provided that the straight line
is constrained to cross the origin [42]. A comparative fit of our proton CT data
shown in figure 5.11 yields gradients of 0.992± 0.017 and 0.999± 0.012 respectively.
The results suggest that the PRaVDA proton CT system behaves comparably to
the LLU/UCSC system. It should also be noted that the Somatom phantom didn’t
contain a lung-equivalent material, however the LLU/UCSC system has benefited
from further development than the PRaVDA system and that imaging the larger,
standard calibration phantoms without the need for a compensator is a significant
achievement.
Further work by the LLU/UCSC Collaboration shows a proton CT scan of
an anthropomorphic phantom [43, 42]. This proved a more significant challenge for
the system, where the accuracy of the RSP reconstruction was reduced, primarily
due to one outlier data point due to cortical bone. This is because in the anthro-
pomorphic phantom, the thickness of the cortical bone is close to the size of the
reconstruction matrix and thus the reconstructed value is distorted by partial vol-
ume effects. Whilst the reconstruction matrix could be reduced in size, the extra
time requirements to collect and process the extra required proton data would hin-
der efforts to bring proton CT closer to the clinic. The reconstruction matrix size
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is also restricted by inherent limitations of the spatial resolution of proton CT due
to multiple Coulomb scattering [22]. One study into the effect of the reconstruc-
tion grid shows that for the same level of Gaussian noise, the distribution of RSP
errors is reduced with the size of the reconstruction matrix, however typically only
small amounts of cortical bone are ever in the path of the proton during treatment
therefore we may be able to tolerate the RSP error in bone [2]. In addition to
the experimental data gathered by the LLU/UCSC Collaboration, a high-resolution
model of the anthropomorphic was generated for use in Monte Carlo simulation [44].
The phantom model was released publicly with the latest version of Geant4. This
model could prove extremely useful in benchmarking imaging modalities against
each other in simulation, as well as being a useful tool to inform the design of better
proton CT systems based on Monte Carlo modelling.
The modern era of proton imaging arguably began with the proton tracking
radiography work done at PSI [40]. Through the use of radiography on a dog’s head,
the water equivalent thickness that each proton travelled through was measured and
compared against calculations done on an x-ray CT image that had been converted
to stopping powers. The gradient of the HU to RSP curve was varied in order
to minimise the errors between measurement and calculation. The error in the
calculated integrated WET was reduced from 3.6 mm to 0.4 mm. Whilst there is no
indication of the percentage magnitude of this error, if we assume that the average
WET of the 20 x 20 cm2 image is 20 cm we can consider the reduction in range error
to be from 1.8% to approximately 0.2%; an order of magnitude’s difference. Similar
improvements were observed in plastic and animal phantoms by performing proton
radiography with a single detector [75], showing that perhaps a full tomographic
reconstruction may not be necessary.
There are shortcomings in the PRaVDA data compared to the proton CT
and DECT data shown here. For example, the PRaVDA system necessitates the
use of a range compensator, which would not be feasible in clinical use where more
irregular geometries will need to be imaged. Secondly, the image size in both of the
examples here is superior to the PRaVDA system. Both the LLU/UCSC Collabora-
tion and the DECT technology demonstrate their ability to reconstruct non-uniform
shapes and larger sizes than the PRaVDA system. A limiting factor in PRaVDA
is the energy resolution of the range telescope as well as the detector sizes. Re-
sults from the LLU/UCSC Collaboration suggest that abutting strips sensors lose a
minimal amount of proton hits and this approach may yield good results if further
development of PRaVDA is to take place. However, a limiting factor in both proton
CT systems is the ability of the detectors to resolve individual proton signals at
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clinical beam currents. This means that the proton CT scan time is still too long
to be considered to be feasible in a clinical work flow.
5.6 Conclusions
Considering the above results, there is a need for further study of the PRaVDA
system. Furthermore, a more detailed study of the effect of RSP errors on range
uncertainty may be necessary, rather than the 1-dimensional study presented by Ba¨r
et al and shown above. A Monte Carlo simulation of the iThemba LABS beamline
and the PRaVDA instrumentation may provide a useful tool for further develop-
ment. In addition, the simulation may be used as a diagnostic tool to investigate the
artefacts in the existing proton CT image. Provided that a Monte Carlo simulation
is validated and can produce realistic results, parameters such as the beam energy,
size of the detector elements and phantom geometries can be modified to study their
effect on the final image.
These conclusions lead to the work discussed in the following two chapters,
where a Monte Carlo simulation of the iThemba LABS beamline is configured to
produce accurate dose distributions compared to water tank measurements, and a
Monte Carlo model of a dosimetric phantom is generated based on an x-ray CT and
proton CT dataset. The Monte Carlo model will allow a direct measurement of the
difference in calculated proton range for the same beam based on the x-ray CT and
proton CT image modalities, as well as a comparison with a direct measurement of
the dose distribution so that the most accurate result can be determined.
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Chapter 6
Commissioning of a Monte
Carlo simulation of the
iThemba Beamline
6.1 Introduction
In this chapter a Monte Carlo simulation of the iThemba LABS beamline is intro-
duced. The Monte Carlo simulation allows study of the beamline and modelling
of experiments. An aim of this thesis is to use Monte Carlo to calculate a dose
distribution in a phantom imaged with proton CT, using the proton CT image, and
compare the simulated dose distribution with an experimental measurement. In or-
der to do this, the Monte Carlo simulation must first be tuned and validated against
experimental data, which is done in this chapter. In order to tune the simulation we
must first demonstrate that the scoring method is robust to geometric changes, such
as the collimator size and the detector size. Secondly, the energy of the primary
proton beam entering the beamline must be optimised. Finally, the I-value of the
sample of polyethylene used in the phantom construction is found by comparing
simulated results against data. Parameters in the simulation were tuned so that the
range of simulated Bragg peaks matched experimental measurements described in
chapter 3.
We opted to tune the I-value of polyethylene because the material comprises
the body of the phantom described in chapter 7. In order to study the proton range
in a Monte Carlo model of the phantom, we want to accurately know the properties
of the materials. The currently accepted I-value of polyethylene is 57.4± 8 eV [57].
Using the Bethe-Bloch equation, this corresponds to an uncertainty in the relative
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stopping power of polyethylene of 3.5%. This translates to a range uncertainty of
greater than 1 mm when modelling the phantom. We seek to reduce this uncer-
tainty by comparing simulated Bragg peaks against water tanks measurements with
a sample of polyethylene in the beam. By adjusting the I-value of polyethylene
in the simulation, we can determine a new I-value for polyethylene with reduced
uncertainty.
6.2 PRaVDASuperSimulation
The PRaVDASuperSimulation (SuSi) is a Geant4-based Monte Carlo simulation
used to model the PRaVDA proton CT system, comprising a modular set-up of
beamlines, phantoms and detector systems. A macro-based control system allows
the user to select a model of either the iThemba LABS proton beamline or the MC40
cyclotron at the University of Birmingham, a range of phantom options and/or
components comprising the PRaVDA pCT system.
Geant4 provides an object-oriented toolkit for performing Monte Carlo sim-
ulations of particle transport written in C++ [76]). Included with Geant4 is a large
collection of validated interaction data that is frequently updated and is used to
accurately model the electromagnetic, hadronic and nuclear reactions that a proton
projectile will undergo.
The simulation of the iThemba beamline was initially developed by Steve
Peterson and Jeyasingam Jeyasugiththanm from the University of Cape Town [77]
in 2009. During the PRaVDA project, the simulation was extended to include
detailed modelling of the PRaVDA instrumentation [78]. Over the course of the
project, physics libraries in Geant4 have been updated. Most significantly, the
I-value of water has been revised from 75 eV to 78 eV [79]. This increases the
simulated range in water by 1.2 mm for the full energy iThemba beam.
Geant4 physics lists provide a modular library of interaction models and
cross-sections allowing the user to specify relevant physics models for their sim-
ulation. In SuSi, the physics list HADRONTHERAPY 1 was selected from the
Hadrontherapy Geant4 examples [80] recommended for medical applications [81].
For the energy range relevant for proton therapy, hadronic interactions are calculated
using the Binary-Ion Cascade (BIC) model. Electromagnetic interactions are han-
dled using the G4EmStandardPhysics option4, the most accurate option for medical
physics applications. Radioactive decay is considered using G4RadioactiveDecayPhysics.
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6.2.1 iThemba beamline geometry
The proton beamline at iThemba LABS geometry is depicted in figure 6.1, taken
from SuSi to provide reference for the following section. The beamline is arranged in
a double-scattering configuration, where two thin scattering plates of high-Z material
are used to generate flat, broad beam at the patient collimator. The principles of
the design are explained in Koehler et al [18].
i The proton beam enters the beamline through a vacuum pipe connected to
the cyclotron. We begin modelling the proton beam in this vacuum pipe as a
general particle source and define a proton energy distribution. Primary protons
are then produced with an energy randomly sampled from this distribution. A
reference ionisation chamber acts as the first scatterer immediately at the exit
of the vacuum window. Steering magnets then act to focus the beam, whilst the
multiwire ionisation chamber monitor constantly monitors the beam position
providing feedback to the steering magnets.
ii The range trimmer plates, lead plate and double-wedge energy degraders act as
an energy selection and tuning system for the treatment beam. The lead plate
is attached to the wedge degraders in a way so that the plate is only in the beam
when the wedges are open. The wedges comprise two blocks of graphite mounted
back to back on a drive mechanism that allows them to be driven together to
provide a variable absorber thickness in order to modify the energy, and therefore
the range, of the beam at the final collimator. The drive mechanism is encoded
such that the range of the beam is within ± 0.5 mm of the requested range,
provided that the energy of the beam is within tolerance. If the energy of the
beam is out of tolerance, adjustments to the range can be made by adding or
removing range trimmer plates just upstream of the energy degraders. Each
range trimmer plate is made of thiolyte, a paper-based compound, measuring
0.622 mm thick with a RSP of 1.343, constituting a water equivalent thickness
of 0.835 mm. Previous work calibrated the vertical wedge position as a function
of the delivered range [77].
iii The multilayer Faraday cup and range monitor were inactive during our experi-
ment and acted as collimators. The occluding ring and central stopper constitute
components in the double-scattering system. Mounted on the second scatterer,
the central stopper removes the central portion of the beam spot and the oc-
cluding ring removes protons with a high angular displacement from the central
beam axis. The remaining protons are then scattered on the second scatterer to
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produce a flat lateral beam profile.
iv Finally, a series of shielding collimators are used to reduce scattered protons and
secondary particles and to ensure a sharp penumbra at the edge of the lateral
beam profile. The final treatment collimator assembly allows the insertion of a
collimator to define the treatment beam size. For the experiments performed at
iThemba we used an 85 mm diameter collimator, with the exception of the mea-
surements taken of the relative stopping power of the tissue equivalent materials,
where the sample materials were held in place by a 15 mm collimator.
In figure 6.1, a modelled water tank is shown at the end of the system. The water
tank is used as a scoring volume. In a scoring volume, a particular property of
the simulation is recorded for further analysis. In this case, we aim to replicate
Bragg peaks so we score the energy lost per unit length by particles inside the
water tank. By binning the data together into steps along the Z-axis, we obtain
a Bragg peak.
6.2.2 Preliminary simulation work
One aim of this chapter is to tune the energy of the proton beam in SuSi so that
simulated Bragg peaks replicate experimental measurements taken with the water
tank, shown previously in chapter 3. The nominal energy of the proton beam enter-
ing from the cyclotron is around 201 MeV however we have no exact measurements
of the experimental conditions on the day. The two measured Bragg peaks we will
use for this work are shown in figure 6.2. These measurements were taken during
an experimental visit to iThemba LABS in November 2016. The first Bragg peak,
referred to as reference beam 1, was one of the first measurements acquired dur-
ing the experimental run prior to our work measuring material RSPs. The second
Bragg peak, reference beam 2, was taken around 4 hours later after all the samples
had been measured. The first Bragg peak was measured with a broad proton beam,
where the collimator aperture was 85 mm in diameter. The second Bragg peak mea-
surement used a 15 mm collimator as it was taken immediately after measurements
of material RSPs. Two major differences can be seen between the Bragg peaks. The
peak to plateau ratio in reference beam 2 is lower than that in reference beam 1.
Secondly the range measurement R80 on reference beam 2 had increased by 0.6 mm
compared to reference beam 1. Whilst it is understood that the energy of beam may
vary slightly affecting the measured range, prior to tuning the energy we wanted to
replicate the characteristics of these two Bragg peaks and understand whether the
use of the collimator affects the measured range of the beam.
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Figure 6.2: The reference Bragg peaks taken with the water tank, as described in
chapter 4. Reference beam 2 was taken around 4 hours after reference beam 1.
Reference beam 1 was delivered with an 85 mm collimator, whilst reference beam 2
was taken with a 15 mm collimator.
Two simulations were performed of the iThemba beamline, one with a final
collimator aperture of 85 mm and one with an aperture of 15 mm. Each simulation
was performed with 250 million primary particles, taking around 600 hours of CPU
time each. Energy deposition was measured in bins of 0.1 mm length along the
beam axis in a central region of the water tank measuring 3 mm high and 1.9 mm
wide. This was done to replicate the spatial properties of the ionisation chamber
used in the water tank measurements. A cubic spline was fitted to the data and
the range R80 was found for each peak. The uncertainty on R80 was also calculated
by considering the RMS residual between the data and the spline fit. In this way,
the contribution of noise due to poor statistics in Monte Carlo can be quantified.
Secondly, the peak to plateau ratio of the Bragg peaks was also calculated.
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Figure 6.3: The reference Bragg peaks with two simulated depth-dose curves showing
the effect of the collimator. Dose was scored in a portion of the water tank the same
size as the ionisation chamber used in the experimental measurements.
Experiment Simulation
Peak to Plateau Peak to Plateau R80 [mm]
Ref . Beam 1
85. mm Coll
3.33 3.24 238.58± 0.11
Ref Beam 2
15. mm Coll
1.7 2.47 238.54± 0.22
Table 6.1: Peak to plateau ratios and ranges for the two simulated beams shown
in figure 6.3, scored using a volume representing an ionisation chamber. Peak to
plateau ranges for the experimental measurements are also included.
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The two Bragg peaks are shown in figure 6.3. They show good agreement
with the reference curves in terms of the peak-to-plateau ratios, shown in table 6.1.
Whilst the energy of the simulated beams has not yet been tuned, the energy source
in the two simulations is exactly the same so we can determine whether the colli-
mator size affects the measured range in the simulation. The two simulated Bragg
peaks ranges agree with each other within error. This suggests that the collimator
does not affect the measured range and thus we must consider that between the two
reference Bragg peak measurements, the energy of the cyclotron changed slightly.
We note that the uncertainty on the beam with the smaller collimator is larger than
the beam with the 85 mm collimator.
Both of these simulations were computationally expensive. In order to tune
the energy we wish to run a large number of simulations. By improving the statistics
of the measured Bragg peak, we could reduce the number of primaries required in
the simulation. One method of achieving this is by extending the scoring volume to
cover the whole water tank. We ran two more simulations to replicate the reference
beam conditions however this time scored the energy deposition in the whole water
tank volume. We were able to obtain sufficient statistics with 4 million protons,
reducing the CPU time to 10 hours per simulation. The results from this simulation
are shown in figure 6.4. TheR80values in each simulation agree within error. The
peak to plateau ratio of the 85 mm collimator beam agrees with that from the ref-
erence experiment. However, the plateau region in the simulation with the 15 mm
collimator does not match with the experiment. The dose in the plateau region dips
before rising to the Bragg peak. This can be explained by considering the lateral
scatter of the proton beam. Immediately after the collimator there will be a pro-
portion of protons with lower energy than the primary beam. These protons scatter
laterally and increase the dose at the front of the water tank. This is not measured
in the reference beam because the dose deposited is outside of the measurement
volume along the central axis. The peak to plateau ratios and ranges are shown in
table 6.2.
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Figure 6.4: The reference Bragg peaks shown with two simulated depth-dose curves
where dose was scored in the whole water tank volume.
Experiment Simulation
Peak to Plateau Peak to Plateau R80
Ref . Beam 1
85. mm Coll
3.33 3.38 238.54± 0.01
Ref Beam 2
15. mm Coll
1.7 2.54 238.45± 0.08
Table 6.2: Peak to plateau ratios and ranges for the two simulated beams shown
in figure 6.4, scored using the whole water tank. Peak to plateau ranges for the
experimental measurements are also included.
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Now we can consider the four results together; each simulation comprises the
same primary particle source and geometry with the exception of the final collimator
and scoring volume size. The two depth-dose curves simulated with the 85 mm
collimator show good agreement with each other, suggesting that for these Bragg
peaks the scoring volume size has little effect on the measured depth-dose curve. The
peak-to-plateau ratio, evaluated by comparing the ratio of the depth-dose curve at
its maximum point and at 50 mm depth in water is 3.38 when measuring using the
whole water tank and 3.24 when measuring using the small scoring volume. The
peak to plateau ratio measured in the water tank data with the 85 mm collimator
is 3.33.
The measurement of the depth-dose curves using the 15 mm collimator in the
simulation appear to be influenced more significantly by the choice of the scoring
volume. The plateau region of the simulated curve with the larger scoring volume
has a decreasing slope before rising to the Bragg peak, unlike the measurement
taken in the water tank. Evaluating the peak to plateau ratio at 50 mm depth
however doesn’t describe this effect very well. The peak to plateau ratios for the
large and small simulated curves are 2.54 and 2.47 respectively. The measured
depth-dose curve has a peak to plateau ratio of 1.7. This suggests that there is a
larger, lower energy component in the proton beam in the measurement that is not
being accounted for in the simulation when using the smaller collimator aperture.
We can conclude that the detector geometry has an effect on characteristics
of the beam measurement, however by using the full water tank as a scoring volume
the required computational time is reduced by a factor of 50. Therefore, we turn
our attention to the distal edge of the Bragg peak. The distal edge of the Bragg
peak is often used to characterise or describe the desired beam in proton therapy.
The iThemba nomenclature uses the point at which the depth-dose curve falls to
50% of its maximum to describe the range of their beam. This appears to be purely
historical. Other centres prefer to refer the range at which the curve falls to 90%.
The range at which the dose falls to 80% is also used widely and approximately
corresponds to the median range of a distribution of protons, or the point at which
the proton fluence falls to 50% of its maximum. Range measurements at R80 of
the four simulated depth-dose curves are compared to see if the collimator size or
scoring volume size has an effect on the measured range. These range measurements
are shown in table 6.3.
Each range measurement has an associated uncertainty that is dependent
on the noise in the simulation. Table 6.3 shows that the reduced detector size con-
tributes to this uncertainty. All of the simulations agreed on the proton range within
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R80 (mm) 15 mm Collimator 85 mm collimator Difference
Detector Volume 238.54± 0.22 238.58± 0.11 0.04± 0.25
Whole Volume 238.45± 0.08 238.54± 0.01 0.09± 0.08
Difference 0.09± 0.23 0.04± 0.11
Table 6.3: Simulated proton ranges in water measured using the whole water tank
volume and a subset of the volume corresponding to the size of the ionisation cham-
ber, using a large and small collimator aperture.
error. The maximum difference in the range R80 between all of the simulations was
0.09 mm. Therefore, we can continue our Monte Carlo work by scoring in the entire
water tank volume, provided that we focus our analysis on the distal edge of the
Bragg peak.
6.3 Tuning of the energy source
6.3.1 Introduction
Simulated primary protons are generated at the entrance of the vacuum pipe in
the iThemba Beamline using a Geant4 general particle source. The general particle
source class allows the user to generate a beam or emittance source with a specified
shape and size, spatial distribution and divergence angle. The energy distribution
of the source may also be specified. In the current application, primary particles
are each assigned a random energy sampled from a given energy distribution. This
is done to model the proton beam generated by the cyclotron as it arrives at the
start of the beamline. Previous simulation of the iThemba beamline specified a
Gaussian energy distribution with a mean energy of 201.36 MeV [77]. With the
revised I-value of water amongst other updates to the beamline model, we tune the
revised simulation to obtain range measurements that match our measured Bragg
peaks. From this we can determine the apparent energy drift in the cyclotron as
well as updating the general particle source for use in further simulation work.
Varying the energy of the source changes the range of the depth-dose curve,
whilst modifying the standard deviation affects the width of the Bragg peak and
therefore gradient of the distal edge. For a beam with a Gaussian energy distribu-
tion, the range in water at 80% of the maximum dose is approximately
R80[mm] = 0.022E
1.77. (6.1)
The exact values of the parameters vary between literature sources as they
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are derived from a fit to ICRU data and are dependent on the limits used for the fit
[82, 15, 7].
The distal falloff, defined as the range at which the dose falls to 20% of
the maximum minus R80 may also be approximated. The following equation is
provided by Gottschalk [7] and corresponds to the minimum expected peak width
as a function of the energy spread of the beam and a range straggling factor, where
the energy spectrum is broadened as a function of the range:
R20 −R80 = 1.3× (σ2En + σ2straggling) (6.2)
where σEn is the standard deviation of the energy spectrum and σstraggling
is a range straggling factor defines as approximately 0.0012 x Range.
These two equations are based on the assumption that R80 is independent
of the energy spread, and that the spread is Gaussian at the point of delivery.
However in the iThemba beamline, the combination of scatterers and the occluding
ring introduce further range straggling so that the distribution at the final collimator
is non-Gaussian. Furthermore an initial study into the accuracy of these equations
using a Geant4 simulation of a Gaussian beam into water showed that R80 varied
by around 1% for beams with energies around 80 MeV when varying the standard
deviation from 1.0 to 5.0 MeV. Therefore, rather than relying on a single defined
measurement point to validate the initial energy spread of the beam, we chose to
validate our simulation against the whole distal edge of the Bragg peak.
6.3.2 Method
The energy spectrum of the general particle source is specified in a macro file that
is used to drive the Monte Carlo simulation. Initially macro files were defined
specifying Gaussian energy distributions with a mean energy of 201.20 MeV to
201.80 MeV in steps of 0.05 MeV, with standard deviations ranging from 0.2 MeV
to 0.8 MeV in steps of 0.05 MeV. Each simulation was run with 10 million primary
particles. These initial simulations were used to inform a region that could be looked
at with higher precision.
Results from each simulation were compared against water tank measure-
ment of a pristine Bragg peak with a nominal R50 of 240 mm by performing a
chi-square test. The water tank measurements chosen for this were the first and
second reference beams taken during an experiment at iThemba LABS in Novem-
ber 2016 and are shown in figure 6.2. As discussed previously, the measured range
of these beams differed by 0.6 mm. Therefore, validating the input energy for each
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Bragg peak allows us to estimate the energy drift of the beam at the entrance of
the beamline.
In the chi-square method, the Bragg peak produced by the Monte Carlo
simulation is treated as a model, and the fit of the data to the model is evaluated.
The chi-square value was evaluated from the peak to the point at which the dose
drops to 10% of the maximum value on the distal edge. This was done to avoid the
choice of detector size and collimator influencing the result. A Savitzky-Golay filter
was used to calculate uncertainties on the water tank data by subtracting the filtered
data away from the raw data. Through this method, a heteroscedastic uncertainty
could be applied, meaning each individual data point had its own uncertainty value
associated with it. The depth-dose curves from the simulation and the water tanks
were scaled such that their peak value was equal to 100, allowing a direct comparison
between the curves. A chi-square statistic was then calculated for each data point
using
χ2 =
∑
z
Dmeas,z −Dsim,z
α2meas,z
, (6.3)
where Dmeas,i is the measurement of dose in the water tank at depth z in
the water tank,Dsim,i is the simulated dose at the same depth and αmeas,z is the
uncertainty in the measured dose, calculated from residuals to the filtered dose
measurement. The simulation corresponding to the minimum chi-square statistic is
then treated as the correct result.
Providing that the model is a good fit, the uncertainties αmeas,z can be scaled
based on the minimum chi-square statistic. If the model correctly describes the
dataset, the chi-square value should be equal to the number of independent variables
in the test. The number of independent variables in the test ν is the number of data
points minus the number of variables in the model. If the reduced chi-square statistic
χ2/ν is close to 1, a scaling factor can be calculated for the uncertainty αmeas,z in
order to set χ2 = ν. This scaling factor is defined as S =
√
χ2
ν . The uncertainty
on the mean and standard deviation of the energy of the general particle source
are then determined by calculating the standard deviation of the chi-square value,
where σχ2 =
√
2ν.
6.3.3 Results
Results from the initial simulations found minimum chi-square values for inputs of
201.25 MeV with σ of 0.35 MeV for reference beam 1 and 201.55 MeV with a σ of
0.55 MeV for reference beam 2. The water tank data set and the simulated results
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are shown in figure 6.5. These simulations were performed with coarse energy inter-
vals and as such no neighbouring values had chi-square values within one standard
deviation of the minimum chi-square values, so we can define the uncertainty on the
energy and standard deviations as +/− 0.05MeV . This uncertainty is insignificant
compared to the apparent energy drift of the cyclotron. However, we continued
to perform more simulations to look at the uncertainty on the input energy of the
second reference beam in order to define the uncertainties there.
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Figure 6.5: Data from the two reference Bragg peaks with simulations overlaid. The
simulation results correspond to the datasets providing a minimum chi-square value.
The gps energy spectrum of both beams was Gaussian. The mean energy of beam
1 was 201.25 MeV with a σ of 0.35 MeV and the mean energy for reference beam 2
was 201.55 MeV with a σ of 0.55 MeV.
The motivation for looking at the uncertainties on the energy input for the
second reference measurement were so that a range uncertainty on the simulation
could be established as a function of the input energy. This range uncertainty was
to be used in to determine the I-value of polyethylene, with the aim of reducing the
I-value uncertainties in the published literature [57]. A water tank measurement
of the RSP of polyethylene was taken immediately prior to this reference beam
measurement, so we can assume that the energy change between these two mea-
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surements was negligible. To ensure that our calculated uncertainty in the I-value
of polyethylene is lower than that offered by the literature, we want to ensure that
we have accounted for the uncertainty in our general particle source.
Fine Tuning
Further simulations were then performed between 201.45 and 201.65 MeV with steps
of 0.01 MeV with the standard deviation varying between 0.40 MeV and 0.60 MeV
in steps of 0.02 MeV. Each was performed with 600 million primaries. By finding
the maximum and minimum energies and standard deviations that provide a chi-
square result within 1 standard deviation of the minimum value we can determine
our uncertainties [60]. In this case, we determined that the mean and standard
deviation of the Gaussian energy spread of the general particle source should be
201.53 ± 0.02 MeV and 0.48 MeV ± 0.08 MeV respectively. These results are
shown in 6.6.
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Figure 6.6: Optimal simulation result for reference beam 2 shown, with 1σ uncer-
tainty highlighted
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6.4 Validation of Material I-values
As discussed extensively in the literature [83, 15, 11], uncertainties in the I-values
published in the literature are a major contributor to proton range uncertainty.
The estimates of Paganetti [15] et al determined that on average, the uncertainty in
published I-values contribute a range uncertainty of upto 1.5%. More recent work
by has sought to reduce this uncertainty to between 0.3 and 0.5 % of the range of
the beam [16] however the currently accepted
When the elements are combined into mixtures or compounds, their respec-
tive I-values are determined either through experimental measurement or through
use of the Bragg additivity rule. One such method, also used to determine the I-
value of water, is to perform range measurements experimentally and compare them
against Monte Carlo simulation, where the I-value of the material of interest can be
defined by the user [84]. By minimising the range difference between the simulation
and measurement, as a function of the I-value, the I-value of the material can be
found.
In the following work, we want to run a Monte Carlo simulation of a proton
dose distribution inside a phantom, using geometries acquired from x-ray CT and
proton CT imaging. In order to compare these simulations to experiment, we need
to validate range of the incoming proton beam. This is done by simulating the ex-
periment with the real geometry and comparing the simulated beam against the film
measurement. The phantom used was constructed using high-density polyethylene
(HDPE). The quoted I-value of HDPE in the literature is 57.4 ± 8 eV. This corre-
sponds to an uncertainty in the relative stopping power of HDPE of about 3% for a
100 MeV proton beam. For a 15 mm sample, this corresponds to an uncertainty of
over 0.4 mm in the range in water of the measurement, and in the following chapter
would correspond to a range uncertainty of around 1.5 mm for a beam with an
approximate range of 50 mm.
Using the energy and standard deviation that we calculated in the previous
section, a new simulation was initiated. In the simulation, a cylindrical sample of
polyethylene was inserted into 15 mm diameter aperture in the treatment collimator,
so that the SuSi simulation replicated the experiment described in chapter 4. The
polyethylene sample has a length of 14.88 mm and a mass density of 0.94 g/cm3,
and these values were used in the simulation.
A new user option was defined in the simulation so that the I-value of the
polyethylene insert could be defined. The simulation was performed using 17 dif-
ferent I-value settings, from 49.4 eV to 64.4 eV in steps of 1 eV. Each simulation
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was performed with 850 million primary protons, scoring the energy deposition in
the whole water tank. A subset of the simulated depth-dose curves are shown in
figure 6.7, alongside the experimental measurement. The range at 80% on the Bragg
peak distal edge, R80 was used to determine the best fit to the data. The range
error, calculated by subtracting the simulated R80 from R80 measured in the water
tank was then fitted as a function of the I-value of polyethylene by rearranging the
Bethe-Bloch equation:
∆R = Aρe,rel × B − ln Ipolyethylene
B − ln Iwater (6.4)
where B = ln 2mec
2β2
β2
− β2 and is a coefficient accounting for the constants
in the Bethe-Bloch equation and the energy of the proton beam.
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Figure 6.7: Simulated Bragg peaks incident on a sample of polyethylene. As the
I-value reduces, the proton range increases. Error bars were too small to be visible
on the water tank data.
The covariance of the fitted parameters was used to determine the 95% con-
fidence limits, shown in figure 6.8. From the fit, we are able to determine the
I-value of the HDPE sample used in this experiment as 50.8 ± 1 eV. This value is in
agreement with the accepted value of 57.4±8 eV however with significantly reduced
uncertainties. It is noted that the uncertainties defined by the covariance matrix are
lower than the random error in the data. We would expect to see a reduction in the
random error by increasing the number of simulated protons however the process is
already computationally demanding. We intend to apply this method to evaluate
the I-values of tissue equivalent materials introduced in chapter 4. In future work,
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Figure 6.8: Results from a Monte Carlo simulation showing the range difference
at R80 between a water tank measurement and a simulation of a nominal 240 mm
range proton beam incident on a 15 mm sample of polyethylene. In the simulation,
the I-value of the polyethylene sample was adjusted to tune the simulation in order
to reduce the error and redefine the I-value of polyethylene.
it would be preferable to take water tank measurements using larger samples as this
would increase the relative range error as a function of the I-value and thus reduce
the need for such high-precision computation.
6.5 Conclusions
The performance of Monte Carlo simulation of the iThemba LABS proton beamline
was validated against experimental measurement. The energy of the proton source
in the simulation was tuned by performing a chi-square test and uncertainties on
the input were defined. Following this work we used the simulation to calculate
the I-value of polyethylene. This method provided a result with lower uncertainties
than the current accepted value. We will use this simulation to calculate proton
dose distributions on image data from proton and x-ray CT.
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Chapter 7
Film Phantom CT: Comparison
of x-ray CT and proton CT
7.1 Introduction
In this final experimental chapter, we introduce a dosimetric phantom designed to
be imaged with the PRaVDA proton CT and measure the range of an incident
proton beam. The motivation behind this design is to test the applicability of
proton CT images in treatment planning. The phantom was also imaged with x-
ray CT and by comparing dose distributions calculated using Monte Carlo on each
image set, we can demonstrate the difference that the imaging modality can make
to the calculated proton range for the same proton beam. The dosimetric phantom
contains a portion of Gafchromic EBT-3 film oriented in the plane of the beam so
that a 2D dose distribution could be recorded. This experiment combines elements
of all the prior work in this thesis to demonstrate the potential use of proton CT in
treatment planning.
7.2 Film phantom design
The film phantom was constructed by University Hospital Coventry and Warwick-
shire and comprises a cylinder measuring 75 mm in diameter manufactured from
high-density polyethylene (HDPE). The phantom is constructed from two halves
measuring 37.5 mm in height. In the lower half, there are two 15 mm diameter
recesses designed to hold rods of tissue equivalent materials, as used in chapter 4 to
measure the RSPs. Rods of LN10 (lung equivalent) and SB5 (cortical bone equiv-
alent) were chosen to maximise the dynamic range of the dosimetric measurement.
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Figure 7.1: Photograph of the film phantom in three parts. The top and bottom
halves are held together with locating pins and a plug holds the film in place.
The measurement was performed using a piece of Gafchromic EBT-3 film located
in a recess behind the two inserts. A photograph of the phantom is shown in figure
7.1.
The film was arranged so that the beam axis is along the plane of the film.
In this orientation, the Bragg peak can be seen along the film and a depth-dose
curve can be extracted. A plug compresses the film to minimise air gaps around
the outside. The EBT-3 film was cut using a computer-controlled vinyl cutter at
the Queen Elizabeth Hospital, Birmingham. This allowed precise and highly repro-
ducible cutting. The size of the film cutouts was optimised by cutting prototypes
and adjusting the size in 50 µm steps in both directions so that the film sat flat in the
cavity with no lateral movement. The shape was chosen to be asymmetric so that
the film could only fit in one orientation, minimising the chances of a non-uniform
film response based on the film orientation [85]. The film recess was tilted with a
1 degree angle to reduce the effect on the measurement of air gaps around the film
[86].
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Protons
Figure 7.2: Photograph of the film phantom after irradiation with the 45 mm range
beam.
7.3 Irradiation at iThemba LABS
Prior to the imaging and simulation work, the phantom was irradiated with a proton
beam at iThemba LABS. The phantom was placed at the isocentre of the beamline
at iThemba LABS, such that the beam was incident perpendicular to the front edge
of the film. A collimator with an aperture of 85 mm was used. The beam current
was of the order of 10 nA and the phantom was irradiated for 4 minutes, delivering
approximately 4 Gy at the Bragg peak. Two irradiations were performed with the
range degrader wedges adjusted inbetween the measurements, such that two proton
beams with different ranges were measured. The film was replaced between the two
measurements. The two beams had nominal ranges of 45 mm and 52 mm in water.
These values were chosen so that we could ensure that the protons stopped inside
the EBT-3 film at 3 measurement points: behind the LN10 inhomogeneity, behind
the SB5 inhomogeneity and through the central portion of HDPE. The relatively
broad range of stopping powers between the LN10 and SB5 samples meant that the
two measurements with different ranges were needed. A photograph showing film
phantom after irradiation with the 45 mm range beam is shown in figure 7.2.
7.3.1 Film Dose Response Calibration
Two calibrations were needed to determine the dose response of the film when
measuring the proton Bragg peak. The first calibration provides the dose as a
function of the optical density of the film. The second calibration corrects for
underreponse when measuring proton Bragg peaks using radiochromic film.
EBT-3 film is a radiochromic film that changes its optical density in response
to ionising radiation. The change in optical density arises from the polymerisation
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Figure 7.3: Schematic of Gafchromic EBT-3 film, redrawn from [85]
of dye monomers in an active layer of the film. A schematic of the layer struc-
ture is shown in figure 7.3. EBT-3 is approximately 270 µm thick and is designed
to be water-equivalent. The optical absorption induced by polymerisation of the
monomers generates a peak at 622 nm, showing the largest change in optical den-
sity in the red spectrum of visible light [85]. This induces a colour change to the
naked eye and the film turns from yellow to blue in appearance. The under-response
when measuring Bragg peaks occurs due to local polymerisation sites saturating in
the presence of high LET protons [87, 88, 89].
Dose Response
The calibration of the dose response as a function of the optical density of the film
was performed by irradiating pieces of EBT-3 film to known doses at the MC40 Cy-
clotron at the University of Birmingham. A 28 MeV proton beam was used. Pieces
of EBT-3 film were arranged perpendicular to the beam axis and the dose delivered
to the film was calculated from the charge measured in a Markus ionisation chamber
located behind the film. The film samples for calibration were from the same sheet
used in the irradiations at iThemba LABS. The calibration was performed from 0.2
Gy to 20 Gy, covering the dynamic range of EBT-3 film.
The film was scanned at Queen Elizabeth Hospital, Birmingham 14 days after
irradiation using an Epson Perfection V700 scanner used for routine film dosimetry
therefore we can assume that any non-uniformity in the scanner response is negligi-
ble. The image was scanned at 96 dpi and the red channel was extracted from the
rgb image for use in the calibration. The pixel values were extracted using ImageJ
and the net change in optical density was calculated for each dose point. This net
change was then fitted against the dose using the function
Dose [Gy] = A×OD + (B ×ODC), (7.1)
where OD is the optical density of the film. The resulting values for A, B
and C were 8.13, 185.15 and 5.45 respectively. The conversion curve is shown in
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Figure 7.4: Conversion curve to obtain dose from measured optical density in EBT-3
film.
figure 7.4. The standard deviation on the optical density measurement is shown as
an error bar.
Bragg Peak Correction
Correcting for the EBT-3 film under-response at the Bragg peak is a particular
challenge for the following work. From the literature, two methods were considered.
The first method, proposed by Zhao et al for EBT film in a film orientation parallel to
the beam axis, involves multiplying the dose measured in the film with a third-order
polynomial [86]. EBT is a different model of film to EBT-3 with a different layer
structure. The polynomial coefficients are derived empirically by fitting the film
measurements to those taken with an ionisation chamber. Zhao et al recommend
applying the correction to EBT film measurements of the beam with an energy
above 100 MeV.
The second method, described by Fiorini et al, proposes a known correction
factor as a function of the mean proton energy at the Bragg peak [88]. The authors
suggest that the correction factor can be extended to cover all proton energies and
the factor is calculated for EBT-2 and EBT-3. To determine the mean energy of the
proton at a given measurement point for the calibration, a Monte Carlo simulation is
used. It was decided that whilst the Fiorini method may be more specific to EBT-3
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film the inhomogeneities in the film phantom make this method impracticable to
apply to our film phantom measurements.
In our calibration we calculate our own correction factors for the polynomial
fit of Zhao et al for the two beams. This is done by fitting a measurement of the dose
in film along the central axis of the film phantom to Monte Carlo model of the same
film phantom in the PRaVDASuperSimulation (SuSi), using the beam parameters
and polyethylene I-value found in the previous chapter. In the simulation, the
wedges were set to provide a beam with nominally 45 mm range-in-water and 52
mm range-in-water, matching the experimental set up of the iThemba irradiations.
Depth-dose curves are extracted for a central portion of the phantom, measuring 1
mm wide.
A 1mm wide region of the EBT-3 film is used to measure the Bragg peak
experimentally. The film measurement is scaled to a percentage depth-dose curve
and is normalised to the simulated Bragg peak in the plateau region, where the
film does not under-respond, such that the first point in the film measurement
corresponds to the same percentage dose as in the simulation. The peak height in
the uncorrected EBT-3 film does not match that of the simulation. A least-squares
fit of the film data to the simulated Bragg peak yields the 3rd order polynomial
correction
PDDcorrected = αPDDfilm + βPDD
2
film + γPDD
3
film + δ (7.2)
where α = 7.21×10−3, β = 1.17×10−4, γ = −8.64×10−7, δ = 5.14×10−3 for
the 45 mm range beam and α = 6.11× 10−3, β = 2.38× 10−5, γ = 7.61× 10−7, δ =
−1.38×10−3 for the 52 mm range beam. The uncorrected and corrected film Bragg
peaks are shown in figures 7.5 and 7.6 along with the simulated depth-dose curves.
Range measurements on each peak were then calculated, by considering the
depth at which the dose falls to 80% and 50% of the dose maximum on each curve.
The range measurements for the simulation, uncorrected film and corrected film
profile are shown in table 7.1 . The relative stopping power of polyethylene is very
close to 1 therefore we can expect to see R50 measurements close to 45 mm. The
simulation performs as expected and we consider this our truth value to which we
compare the film measurements. The corrected film measurement is more accurate
at R80 than the uncorrected film measurement when compared to the simulation
which is to be expected as we attempted to fit the data to the simulation result. We
opted to continue to use the Zhao correction in our film analysis in the next section,
however we would consider the Fiorini correction in further work.
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Figure 7.5: Uncorrected and corrected percentage depth-dose curves for the film
phantom recorded in EBT-3 film, compared with Monte Carlo simulation. Nominal
range is 45 mm.
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Figure 7.6: Uncorrected and corrected percentage depth-dose curves for the film
phantom recorded in EBT-3 film, compared with Monte Carlo simulation. Nominal
range is 52 mm.
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R80 (mm) R50 (mm)
45 mm Simulation 43.2 45.1
Nominal Uncorrected film 42.8 45.4
Range Corrected film 43.1 45.3
52mm Simulation 50.7 52.7
Nominal Uncorrected film 51.3 53.8
Range Corrected film 50.3 52.4
Table 7.1: Measured ranges in the polyethylene phantom in EBT-3 film and simu-
lated depth-dose curves. Note that the uncorrected R50 measurement in Gafchromic
film was slightly higher than expected. The uncertainty on the nominal range of
the beam is ± 0.5 mm due to tolerances on the wedge position. for this reason the
simulation range was increased to nominally 52.5 mm to match the film. However
we continue to refer to the beam as 52 mm in range as this is consistent with the
nominal range in the experiment.
7.4 Proton CT and X-ray CT Image Comparison
Proton CT and X-ray CT images of the film phantom were acquired. A slice from
each image is shown in figure 7.7. The proton CT scan of the film phantom was
completed in November 2016 at iThemba LABS with the same set up as described in
chapter 6. A cylindrical range compensator was used to ensure that protons stopped
in the range telescope. Data was acquired from the phantom at 90 angles, using
steps of 2 degrees and the image was reconstructed using approximately 2 million
protons per angle using the non-linear path backproject-then-filter algorithm.
The x-ray CT scan was performed at University Hospitals Coventry and
Warwickshire using a modified radical brain protocol. The phantom was scanned
inside a 20 cm diameter cylindrical water chamber in order to reduce the effect of
beam hardening artefacts on the quantitative accuracy of the Hounsfield Unit (HU)
measurements. The HU measurements were converted to RSP using the conversion
curve defined in chapter 4 and the water chamber was removed in post-processing
by applying a binary mask to a 75 mm circular region centred on the phantom. As
a result of the mask, aliasing artefacts occur at the edge of the phantom.
The proton CT image here appears to be affected by noise more significantly
than the proton scan of the Bauble phantom shown in a previous chapter. This can
be explained because the number of protons used here in the reconstruction is much
lower. It is also noticeable there are no significant streak artefacts across the image,
as seen in the Bauble phantom. That is because we do not expect any protons to
escape the rear of the range telescope. 1D profiles of the x-ray CT derived stopping
power map and the proton CT scan are shown in figure 7.8. These profiles were
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pCT X-ray CT
Figure 7.7: Proton CT and x-ray CT images from the film phantom. The aliased
edges on the x-ray CT are from cropping the image to remove the background water
chamber.
taken across the phantom through the two insert materials. The stopping powers
of the materials as measured by the water tank are also overlaid.
The stopping power of the SB5 cortical bone insert is overestimated by x-ray
CT. This is consistent with the result observed in the Bauble phantom and can be
explained by the inability of the x-ray CT conversion curve to cope with the specific
properties of the SB5 insert. Otherwise, the performance of the x-ray CT imaging
is relatively good.
The proton CT scan reconstructs the stopping power of the SB5 insert ac-
curately, however the quantitative RSP value of polyethylene is systematically un-
derestimated consistently across the phantom by around 7.5%. The RSP of LN10 is
also underestimated in this dataset. The reconstructed RSP of LN10 in this dataset
is lower than that reported in the proton CT scan of the Bauble phantom, however
this was not investigated further.
7.5 Simulated Dose Distributions
This final piece of work considers the use of proton CT imaging for dose calculation.
The proton CT image and x-ray CT dataset for the film phantom were used to
construct a voxelised phantom geometry in Geant4 for use with the SuSi. Two
proton beams were simulated incident on the phantom geometries to replicate the
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Figure 7.8: Cross sections taken through the two inhomogeneities of the phantom
in the x-ray CT and proton CT images.
film irradiation experiment performed at iThemba. By using the EBT-3 film as a
truth measurement, the accuracy of the dose calculations based on x-ray CT and
proton CT can be evaluated by considering simulated proton ranges and comparing
them against the film.
7.5.1 Geant4 DICOM import
In order to construct the voxelised phantom geometry in Geant4, modifications were
made to the SuSi code to incorporate new functions based on classes included in
the Geant4 DICOM example. The DICOM file format is a standard file format
for medical imaging, allowing standardized transfer of information between medical
computer systems. The DICOM file contains a header, with tags specific to the
imaging modality used and the image is then stored as a binary array of integer
values. The tags in the DICOM header provide specific information about the
image including the pixel size, slice size and the relative location of each slice [90].
With this information, a voxelised geometry can be constructed.
Each CT scan was converted into a series of text files, each text file containing
the pixel information in one slice. Two 2D arrays in the file correspond to a map
assigning a material to each pixel and a second map containing the mass density of
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Figure 7.9: Visualisation of a single slice of the proton CT scan phantom geometry
shown at the beam isocentre in SuSi. Also visible are the treatment collimator
assembly and reference ionisation chamber.
the material each pixel. The Geant4 function reads in the information in the text
file and produces voxels with the assigned material type and sets the mass density
of each voxel based on the text file.
Using the proton CT and x-ray CT data sets, RSP maps of the phantom were
produced for each slice. The proton CT image directly corresponds to the RSP of
each voxel, whilst the HU measurements of the x-ray CT image required conversion
to RSP. For both data sets, a binary mask measuring 75 mm in diameter was used
to segment the phantom geometry from the background air. To perform the most
direct import of RSP information into SuSi, each voxel comprising the phantom
geometry had its material set as water. The mass density of each pixel was then
equal to the RSP. The location of the imported phantom geometry was set as the
proton beam isocentre, corresponding to the position used in the experiment. An
image showing a single slice of the proton CT-based geometry in the SuSi simulation
is shown in figure 7.9.
7.5.2 Scoring
Energy deposition in the phantom was scored in 0.1 mm x 0.1 mm bins in the plane
of the phantom in 10 slices containing the inhomogeneities. To reduce aliasing
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artefacts related to the particle step length in the simulation, the dose for each
proton was deposited at a random point along the step length. Aliasing occurs
when the radiation length of the interaction processes is larger than the voxel size.
For efficiency Geant4 calculates a compounded proton path through the step length
corresponding to the radiation length of the material that the proton is in. However,
Geant4 also requires that the step finishes at a geometric boundary. If post-step
or pre-step energy deposition is recorded, then voxel boundaries become apparent
on the measured dose distribution. By depositing the dose at random points, the
dose recording is more evenly distributed. For consistency between the proton CT
scan and x-ray CT scan, where the voxel sizes are 1 mm and 0.3 mm respectively,
a maximum step length of 0.1 mm was set in the DICOM volume so that the voxel
sizes did not influence the simulated dose distributions.
7.5.3 Results
Two simulations were performed using each imaging dataset. In the first simulation
the wedges were set in the simulation to deliver a range of 45 mm range in water,
and in the second simulation the range was set to 52 mm range in water. The dose
distributions in the phantoms for each simulation are shown in figure 7.10. Figures
7.11 and 7.12 illustrate the difference in the proton distributions calculated based on
the x-ray CT and proton CT image. In these figures, absolute dose difference was
calculated between the dose distributions calculated on the x-ray CT and proton
CT image sets and normalised so that the regions with the largest dose difference
are equal to 1. This difference map for the 45 mm and 52 mm range beam is overlaid
on to the proton CT image and highlights the regions affected the most by range
error between the x-ray CT and proton CT images.
Bragg peaks in three regions of the phantom are shown in the following
figures. The locations of these profiles is shown in figure 7.13. We did not include
LN10 using a 52 mm range beam in this analysis because the range of the proton
beam ended outside the EBT-3 film window, therefore we could not resolve the
Bragg peak. In these figures, the Bragg peak was taken along in a 1 mm cross-section
through the centre of the phantom and the centre of the both of the inhomogeneities.
The range is reported as the depth in the phantom as measured along a central
profile, neglecting the circular structure of the phantom. The Bragg peaks are
taken from measurement using EBT-3 film and the two simulations. Each curve is
normalised to the maximum value at its peak to give a depth-dose curve. From these
depth-dose curves, the proton range (R80) was calculated and compared amongst
the measurements and an absolute range error and a percentage range error were
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Figure 7.10: Image showing the 2D dose distributions from two different proton
beams in phantom geometries generated from x-ray CT and proton CT images.
calculated. These are shown in table 7.2.
The range error based on the Monte Carlo dose calculations is considerably
higher when using the proton CT image compared to x-ray CT. This is expected
because of the proton CT dataset reconstructed the RSP of polyethylene inaccu-
rately. However, the percentage range error reduced for proton CT when LN10 and
SB5 inhomogeneities are introduced, despite the RSP of LN10 being significantly
underestimated in the proton CT data set. This is because the amount of polyethy-
lene that the beam travels through is reduced. The consistent nature of the range
errors demonstrates that the image modality is relatively robust for dose calcula-
tions in the presence of inhomogeneities, despite a systematic error in the RSP of
polyethylene. To put these results into a clinical context, typically a margin of the
order of 3.5% + 1mm is used when planning a proton therapy treatment, therefore
range errors of 2.2 mm and 2.4 mm would be acceptable for a 45 mm and 52 mm
range beam respectively.
The simulation based on the x-ray CT image shows good performance when
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Figure 7.11: Relative dose differences between dose maps calculated on proton CT
and x-ray CT images for a beam with nominally 45 mm range in water.
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Figure 7.12: Relative dose differences between dose maps calculated on proton CT
and x-ray CT images for a beam with nominally 52 mm range in water.
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Figure 7.13: Schematic illustrating the location of the Bragg peaks analysed in this
section.
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Figure 7.14: Depth-dose curves from simulations of a 45 mm range beam into the
phantom based on x-ray CT and proton CT images compared with film measure-
ment, through the centre of the phantom.
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Figure 7.15: Depth-dose curves from simulations of a 45 mm range beam into the
phantom based on x-ray CT and proton CT images compared with film measure-
ment, through the SB5 inhomogeneity.
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Figure 7.16: Depth-dose curves from simulations of a 45 mm range beam into the
phantom based on x-ray CT and proton CT images compared with film measure-
ment, through the LN10 inhomogeneity.
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Figure 7.17: Depth-dose curves from simulations of a 52 mm range beam into the
phantom based on x-ray CT and proton CT images compared with film measure-
ment, through the centre of the phantom.
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Figure 7.18: Depth-dose curves from simulations of a 52 mm range beam into the
phantom based on x-ray CT and proton CT images compared with film measure-
ment, through the SB5 inhomogeneity.
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Film Simulation - proton CT Simulation - x-ray CT
Bragg Peak Range Range Error Error Range Error Error
(mm) (mm) (mm) (%) (mm) (mm) (%)
HDPE, 45mm Beam 43.3 45.0 1.7 3.9 % 43.7 0.4 0.9 %
SB5, 45mm Beam 34.5 36.8 2.3 6.6 % 33.9 0.6 -1.7 %
LN10, 45mm Beam 55.9 58.2 2.3 4.1 % 53.4 -2.5 -4.5 %
HDPE, 52mm Beam 49.6 52.9 3.3 6.6 % 50.0 0.4 -0.8 %
SB5, 52mm Beam 41.7 44.8 2.1 5.0 % 40.7 -1.0 -2.4 %
Table 7.2: Proton ranges in the phantom determined from Bragg peaks located in
the cente of the phantom and behind the LN10 and SB5 inserts. The range referes fo
the R80 measurement determined from the Bragg peak. Range errors are calculated
for the two simulations by subtracting the range as recorded in EBT-3 film, and
a percentage range error is calculated. HDPE is an abbreviation of high-density
polyethylene.
calculating proton range in polyethylene however the accuracy is worse when cal-
culating the range of protons that have propagated through SB5 and LN10. The
magnitude of the errors for beams that have propagated through the LN10 inho-
mogeneity is similar to the magnitude of the error seen in proton CT simulation,
albeit in an opposite direction. This is because the x-ray CT image overestimated
the stopping powers of LN10. The range error behind SB5 is slightly lower. The
large variation in the range errors suggests that, despite the reduction in absolute
errors in soft tissue, there may be more range uncertainty associated with the use
of x-ray CT when compared with proton CT over a broader range of tissues. These
errors are all within the 1 sigma uncertainty on RSP estimation calculated by Yang
et al for lung, soft tissue and bone [2].
The mean percentage range error based on the proton CT dose calculation is
5.24%, with a standard deviation of 1.2%. The mean percentage range error based on
the x-ray CT calculation is -1.7% with a standard deviation of 1.7%. Considering the
results of the range uncertainty analysis done in the previous chapter and reported
by Ba¨r et al [63], we can begin to realise the potential for proton CT to reduce
range uncertainties. Whilst we see a systematic error, caused primarily by the RSP
error in polyethylene, the standard deviation in the proton CT range error results
is lower than that in x-ray CT. This suggests that the proton CT system behaves in
a more predictable manner when faced with different types of materials than x-ray
CT, albeit with some systematic error. There is a likelihood that the systematic
error was caused by experimental error, therefore we conclude that further study is
needed to investigate the source of this error.
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7.6 Discussion
Presented in this chapter is a framework for evaluation of the PRaVDA proton CT
system. Despite the poor performance of the proton CT system in this instance, to
the author’s best knowledge this is the only direct comparison of range calculations
on experimental results from proton CT and x-ray CT images, validated against
a direct measurement. The performance of the proton CT system in this instance
clearly suffers from some systematic error, and therefore attention should be focused
on the methodology. The PRaVDA proton CT system is a prototype system in its
first stage of development and therefore we would expect improved results with
further work.
The evaluation framework chosen in this chapter was decided upon to treat
x-ray CT and proton CT fairly and without bias by using experimental measurement
to validate the performance of the two imaging modalities. The framework may be
improved in a number of ways as an evaluation framework for a clinical proton CT
system. For example, the user may choose to use a clinical treatment planning
system in the place of Monte Carlo simulation. For example, it was originally
intended to plan nominally the same “treatment” on x-ray CT and proton CT images
of the phantom, and then deliver them to see the range difference on film. However
the nature of data acquisition, processing and reconstruction with PRaVDA meant
that this was impossible during the experimental time we had available.
In a further evaluation framework, the user may choose to use a more clin-
ically relevant phantom featuring anatomical geometries or even biological tissue.
For example, a study to evaluate the use of dual-energy x-ray CT for proton ther-
apy was performed using isolated range extinction measurements of animal tissue
[91]. The range extinction method described in the literature highlights a shortfall
in EBT-3 film used in this experiment. In order to accurately characterise the re-
sponse of Gafchromic EBT-3 film, even for relative dosimetry, one needs to know the
exact energy of the protons at the end of their range. We can determine this energy
through the use of Monte Carlo simulation [88] however validating this becomes
quite complicated.
The development nature of the PRaVDA proton CT system is evident through-
out the results; the presence of image artefacts that can be explained by experimental
error, limitations in the dynamic range of the detectors and experimental anoma-
lies such as the range telescope calibration curve not accurately measuring residual
proton range. The reconstruction method is also novel and relatively untested.
The system in particular appeared to reconstruct the RSPs of cylindrical phantoms
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around 5% lower than expected, corresponding to a WET difference of around 4
mm. This was also observed in a cylindrical animal tissue phantom, containing a
lamb chop, that is not shown in this thesis. No explanation has yet been offered
as to why this is, but it could be linked to the range telescope calibration or the
compensator correction. The range telescope calibration (see chapter 2) deviates
from the expected values as the water equivalent thickness of the object decreases.
The two cylindrical phantoms were constructed mainly from polyethylene and agar
gel respectively, thus meaning they had a lower WET than the spherical Bauble
phantom. Secondly, the use of a compensator made from PMMA with a higher
RSP than the two phantoms means that the phantom and compensator would have
a non-uniform WET distribution across the phantom body. An assumption in the
reconstruction code when applying the compensator correction could therefore be
causing a systematic error.
7.7 Conclusion
In this chapter, a dosimetric phantom was imaged using x-ray CT and proton CT
and irradiated using the beam at iThemba LABS. A measurement of the Bragg
peaks inside the dosimetric phantom, taken using EBT-3 film was compared against
simulated Bragg peaks calculated in phantom geometries generated using the proton
CT and x-ray CT data sets. By doing this, we demonstrate that the accuracy of
proton CT and x-ray CT for use in treatment planning could be evaluated. How-
ever, the developmental nature of the PRaVDA proton CT system does not provide
relevant results.
X-ray CT performed robustly when used to evaluate proton range in polyethy-
lene however underestimated the range of the protons propagating through SB5 and
LN10, with a mean range error -1.7% and a standard deviation of 1.8%. Despite
increased accuracy in determining the RSP of SB5, in the film phantom the RSP
of polyethylene and LN10 was vastly underestimated leading to overestimation of
proton range with a mean range error of 5.8% and standard deviation of 1.2%.
Range error in the proton CT image is due to issues reconstructing the quan-
titative RSP value of HDPE accurately. Further work needs to be done in this area
before considering the impact of these results. The improved accuracy of RSP re-
construction shown in the Bauble phantom shows that proton CT would be a valid
candidate for dose calculation, however the advantage of the film phantom is the
ability to perform dosimetric measurements in order to compare the calculation to
experimental measurement.
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Chapter 8
Conclusions
In this thesis, a prototype proton computed tomography system is introduced, de-
signed to accurately reconstruct proton stopping powers for use in proton therapy.
An experimental demonstration of the accuracy of proton CT is performed, and
we report the relative stopping powers of tissue equivalent materials measured by
proton CT with an accuracy of better than 1.3% in plastic materials mimicking soft
tissue and bone, when compared to stopping power measurements taken using a
water tank. The effect of stopping power accuracy on range uncertainty is tested by
modelling the range error introduced in a 1D Bragg peak due to the distribution of
stopping powers errors in the proton CT measurement. The range error is compared
against calculations performed for dual-energy x-ray CT reported in the literature
[63]. The results from this test show that if artefacts in the proton CT image of the
Bauble image are corrected for then the proton CT system may perform marginally
better than dual energy x-ray CT in terms of reducing proton therapy range un-
certainty when compared to single energy x-ray CT. Sources of the image artefacts
were investigated and an explanation as so their sources are offered. The presence
of the streak artefacts appears to be caused by the effective WEPL measurement of
high energy proton being clipped by the dynamic range of the calorimeter. A second
ring artefact is present due to misalignment of the compensator during experimen-
tal measurement. A correction can be applied to the latter artefact. The former
artefact would require an improved proton range measurement system capable of
resolving protons with a higher range or energy.
In terms of RSP accuracy demonstrated with the Bauble phantom, the re-
sults from the PRaVDA proton CT system are slightly poorer than those from the
LLU/SCSC phase-II proton CT scanner, who have so far provided the best experi-
mental proton CT results [29] demonstrating accuracy of better than 1%. However,
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LLU/SSC obtained their best results after many stages of optimisation to the cal-
ibration of their range measurement as well as improvements in the reconstruction
algorithm [55]. With further optimisation, we would expect PRaVDA to similarly
improve the RSP accuracy. A limitation to the optization of PRaVDA has been the
availability of experimental time, however with a validated Monte Carlo beamline
model there is a possibility to perform and optimise simulated CT scan performance
prior to designing a new system.
One result that requires immediate further study is the proton CT scan of the
film phantom shown in chapter 7. With the film phantom, we demonstrate Monte
Carlo dose calculation on a proton CT image. The calculated proton range is com-
pared against a calculation on an x-ray CT image and an experimental measurement
performed with EBT-3 film. It was determined prior to the comparison that the
RSP of polyethylene in the film phantom was reconstructed incorrectly and this
with significantly influence the range calculation. As such, we see range errors upto
6.6% in Bragg peaks calculated on the proton CT image in a homogeneous medium.
However the result does not get worse when inhomogeneities are introduced. It is
possible that a systematic error in the data exists and this requires further investi-
gation. However, we demonstrate that we can calculate dose distributions on proton
CT data. In the literature, there are reports of dose distributions being calculated
on simulated proton CT data as well as x-ray CT data [92], however to our knowl-
edge this is the first report of dose calulcations performed on experimental proton
CT data. We note that the LLU/SSC report an intention to do dose calculations
on validated simulated proton CT data using a clinical treatment planning system
however no results have yet been published [44].
Further development of the PRaVDA system should focus on improving the
range telescope. The artefacts arising in the Bauble phantom proton CT scans have
their origins in the lack of dynamic range in the current range telescope. We note
that the LLU/SCSC “hybrid” range-energy detector, using scintillator technology,
meets the demands for WET resolution in a proton CT detector and has suitable
dynamic range to resolve the range of individual protons in a beam with a nominal
energy of 200 MeV [93]. In contrast, the current PRaVDA range telescope cannot
resolve protons above an energy 80 MeV. A possible approach could be to use CMOS
active pixel sensors, an approach originally considered by PRaVDA [51]. Obtaining
proton signal sizes from the CMOS sensor would allow a solid-state “hybrid” ap-
proach to be taken, where the energy of individual protons may be determined from
the size of the measured signal in the CMOS sensor. A proton CT project based at
the University of Bergen demonstrate the use of CMOS active pixel sensors with a 2
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kHz frame rate in a range detector [48], with the design comprising 41 layers sepa-
rated by aluminium absorbers with a higher WET than the PMMA absorbers used
in the PRaVDA system allowing them to resolve proton energies of up to 230 MeV.
With their tracking algorithm they demonstrate that they are capable of resolving
close to 106 protons per second, approaching the rate required for a clinically usable
proton CT system. However this tracking rate requires a proton beam with a sparse
spatial distribution. Improved proton tracking may be required for modern proton
therapy systems with a spot-scanning design, where a high intensity proton pencil
beam is magnetically scanned across the patient.
To conclude, we demonstrate a prototype proton therapy system with initial
results comparable to another research proton CT scanner. Simple range uncertainty
calculations suggest a possible advantage for proton CT over dual energy x-ray CT,
however we do not yet have a robust system and we see systematic errors in the
reconstruction of the film that need further investigation. All of the images acquired
with the PRaVDA system have been performed at relatively low energies on simple
phantoms that do not replicate patient geometries. Further development of the range
telescope would be required in order to improve the system, however there are still
a number of technical and practical challenges to overcome before the technology
becomes applicable in a clinical setting.
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